Table Of Content

Index of Authors for Volume 32 ABBONDANZO, S.L., 1327 Bell, A., 734 Cai, Y.-C., 1087 Abdulkadir, S.A., 935 Bell, W.C., 856 Cain, J.W., 18 Abiko, Y., 880 Benhattar, J., 105 Cameron, J.L., 638 Abraham, S.C., 447, 455 Benigni, E., 656 Campbell, K-P., 791 Abramovich, C.M., 649 BenningtonJ,. , 222 Canavese, G., 1094 Abramson, D., 537 Bento, M.]., 487 Cannizzaro, L.A., 615 Addis, V.M., 521 Beranek, J.T., 894 ao ‘apron, F., 320 Adeyi, O.A., 660 Berman, J., 578 sarbone, J.M., 935 Adsay, V., 513 Bernardi, M., 656 varlson, N., 113 Aita, K., 887 Bethwaite, P.B., 590 varnevale, S., 500 Akalin, A., 889 Bhargava, R., 1344 varnot, F., 904 Akiyama, H., 237 Bhattacharyya, A.K., 1283 Jaron, R., 842 AAllbaomreedsa-,S aaFv.,e dr1a19,7 J., 753 Biegel, J.A., 884 tasetta, G., 468 Bildirici, K., 889 ‘astro, C.Y., 863 AAAllleeesxxsaaannndddeerrri,,n i,JC ..,B C..1,,1 861470 10 3 BBiilrogu, s,F .,A .4M6.1, 590 ARCasAAtaaAtRsaRlu osAn,a L, L .W,. ]5J.6,9 935 Alexander, P., 178 Blandenier de Suarez, C., 149 CCeecscaarremlalni,, CE..,, 945 , 288 Ali, N., 113 Blanes, A., 1232 Chadburn, A., 339 Alison, M.R., 1216 Blaser, M.J., 264 Chambonniére, M.-L., 1166 Allen, E.A., 1323 Bleiweiss, [.J., 583 Chan, J.K.C., 1403 Alli, P.M., 1318 Bobak, J., 119 Chan, S.H., 42 Allsbrook, W.C. Jr., 74, 81, 1278, 1417 Boddi, V., 529 Chan, T., 1209 Alm, P., 311 Boldorini, R., 656 Chanel, S., 129 Almagro, U.A., 1300 Bonatz, G., 605 Chang, M.S., 297 Alonso, P.L., 1023 Bonvoust, F., 327 Charney, D., 954 Amato, G., 1407 Bordessoule, D., 196 Charoenratanakul, S., 741 Amatya, V.J., 970, 1203 Bordi, C., 1094 Chau, Y., 1403 Ambinder, R.F., 963 Bornstein-Quevedo, L., 1252 Chen, B.-F., 479 Amin, M.B., 74 Bostwick, D.G., 74 Chen, C.-L., 1240 Amo-Takyi, B.K., 559 Botchan, A., 36 Chen, H., 479 Amunni, G., 360 Boucher, D., 230 Cheng, S.-H., 1016 Anderson, R.E., 459 Boudousquie, A.C., 178 Chertcoff, A., 500 Aozasa, K., 1403 Boulland, M.-L., 196 Chetty, R., 89 Appelman, H.D., 1143 Bouyounes, B., 18 Cheunkongkaew, W., 741 Arai, S., 1050 Bova, G.S., 417 Chew, K., 292 Argani, P., 506 Bovicelli, A., 4 Chi, J.G., 623 Argtielles, R., 569 Bovicelli, L., 4 Chirala, M., 940 Ariza, A., 227 Bozzini, J.P., 500 Cho, E.Y., 954 Arkadopoulos, N., 1371 Braasch, J.W., 18 Cho, Y.J., 297 Armengol, M.-P., 227 Bragg, S.L., 750 Choi, H., 1300 Aronson, A,J., 205 Bramante-Schreiber, L., 803 Choi, H.-Y., 643 Arpesella, G., 1078 Brambilla, C., 918 Choi, Y.-J., 1125 Asuwa, N., 242 Atherton, J.C., 264 Brambilla, E., 918 Chong, S.M., 42 Brat, D.J., 638 Chott, A., 545 Au, W.Y., 126 Aubert, J.-P., 274 Brechot, C., 904 Chung, W.-K., 643 Ayata, G., 814 Brichon, P.-Y., 918 Chung, Y.-F., 1016 Azzoni, C., 1094 Bringuier, A.-F., 1190 Ciepy, K., 428 Bronner, M.P., 368 Cihak, R.W., 139 Cina, S.]., 630 Brooks, ].D., 441 Brooks, J.S.J., 139 Cinti, C., 4 BA, N., 327 Brousset, P., 95, 288 Cleton-Jansen, A.-M., 1416 Baba, M., 1064 Bruch, L.A., 156, 1102 Cohen, B.H., 649 Bae, J.H., 250 Cohen, M.B., 791 Buchler, M.W., 1174 Bajani, M.D., 750 Cohen, R.J., 242, 441 Buckner, S.-B., 1323 Bakker, A., 1039 Buhring, H.-J., 545 Coindre, J.-M., 105 Baldetorp, B., 311 Collin, F., 105 Buisine, M.-P., 274 Baloglu, H., 615 Comin, C.E., 529 Burke, L., 129 Banner, B., 1087 Bussaglia, E., 569 Cooke, H.J., 36 Bansard, J.-Y., 1209 Copin, M.-C., 274 Bussolati, G., 468 Baranowska-Daca, E., 1125 Cordon-Cardo, C., 537 Butler, D.R., 1309, 1318, 1323 Barranco, C., 1197 Corleto, V.D., 1094 Barrios, R., 863, 1125 Costa, S., 4 Batts, K.P., 357 Coulange, C., 282 Baumforth, K.R.N., 963 Coulomb-L’Hermine, A., 320 Becchina, G., 1407 CABALLERO, A., 500 Cover, T.L., 264 Beckwith, J.B., 506 Cagle, P.T., 863, 1059 Crafa, P., 1094 Bedossa, P., 327 Cai, D.X., 156 Crevon, M.-C., 320 1423 HUMAN PATHOLOGY Volume 32, No. 12 (December 2001) Crum, C.P., 479 FANBURG-SMITH, J.C., 976 Ghazizadeh, M., 1050 Cunnane, M.F., 1140 Fayt, I., 135 Gianani, R., 119 Cviko, A., 479 Fecko, A., 690 Gilchrist, A., 1269 Fekete, E., 50 Cill, J., 447 Feldmann, G., 1190 Gilliard, G., 149 Fend, F., 1264 Gilson, T., 216 Fernandez-Figueras, M.-T., 227 Giordano, A., 4, 360 D’Acatl, V.D., 734 d’Amati, G., 1078 Ferno, M., 311 Giordano, F., 1022 Ferrandina, G., 4 Giorgi, R., 282 Daa, T., 352 Ferrans, V.J., 188 Glaser, D., 842 Daimaru, Y., 1203 Fetsch, J.F., 704, 715, 873 Glickman, J.N., 1087, Daniel, L., 282 Fiche, M., 129 Gloeckner, K., 1136 Darai, E., 1190 Figarella-Branger, D., 282 Gobbi, H., 785 Dargent, J.-L., 135 Dargére, D., 3 27 FigurskiJ,. , 690 Goerz, E., 241 Filipovich, A.H., 963 Goldblum, J.R., 368, 379 Date, Y., 237 Finkelstein, S.D., 1039 Gomibuchi, M., 1050 Davis, J.R., 1283 Finn, W.G., 66, 1277 Gordon, F.D., 814 Davoli, C., 1094 Fiore, F., 1078 Gorstein, F., 1, 567, 1027, 1417 Day, M.L., 690 Fischer, G., 242 Gosselin, B., 274 Dayal, Y., 1184 Fisher, S.1., 1327 Gould, V.E., 1356 de Bolos, C., 1197 Flavell, J.R., 963 Graham, A.R., 1283 de Miguel, M., 1232 Fleischer, A., 559 Graham, D.Y., 698 de Sousa, C.P., 487 Fletcher, C.D.M., 1382 Green, L.K., 863 Dehner, L.P., 156, 1102, 1109 Florendo, C., 292 Greenson, J.K., 368, 379 Delahunt, B., 590 Flores, K.G., 926 Greil, R., 1264 Delle Fave, G., 1094 Fontaine, H., 904 Grenko, R.T., 889 Delsol, G., 95, 288 Ford, J.C., 434 Grignon, D.J., 513 Demetriou, A.A., 1371 Fortunato, M., 656 Grillo, P., 1078 Demetris, A., 1334 Foster, C.S., 567, 1154, 1417 Grizzle, W.E., 856 Demopoulos, R.I., 808, 984 Frahm, S.-O., 605, 1376 Grumet, M., 396 DeschatretteJ,. , 327 Friedlander, D., 396 GuarnerJ,. , 31, 750 Descour, M.R., 1283 Friess, H., 1174 Guillou, L., 105 Dettori, G., 698 From, L., 50 Gulley, M., 963 Devilard, E., 461 Frost, A.R., 856 Gunther, K., 559 DeVries, S., 222, 292 Frost, M., 119 Guo, L., 1071 Dhodapkar, K.M., 396 Fujii, T., 410 Guo, X.-D., 233 di Gioia, C.R.T., 1078 Fujikawa, K., 1363 Di Pasquale, M., 24 Fujimoto, S., 163 Diaz-Cano, S.J., 1232, 1415 Fujiwara, M., 1050 Diciolla, F., 1003 Fukase, M., 796 Haas, M., 205 DieboldJ,. , 129 Fukuhara, T., 970 Haber, M.M., 368, 379 Dini, S., 529 Fukushima, N., 834 Haioun, C., 196 Dirnhofer, S., 1264 Fuller, C.E., 1102 HHaallep,e riLn.P,. , D.9,2 63 1 Domer, P., 205 Funamoto, Y., 945 Donnellan, R., 89 Fung, J.J., 1334 Hamada, T., 410 Donoghue, M., 205 Fung, K.-M., 1277 Hamazaki, S., 1272 Dore, M.P., 698 Furman, J., 1109 Han, S.Y., 250 Dorfman, D.M., 1382 Furuya, M., 163 Harada, K., 302 Drews, R., 1269 Harasawa, S., 237 Druet-Cabanac, M., 196 Hardisson, D., 763 Dudas, M., 537 Dugan, J.M., 18 GALANAUD, P., 320 Hardt, N.S., 884 Galateau, F., 320 Harmon, W,]., 630 Dundar, E., 889 Galateau-Sallé, F., 129 Hart, J., 368, 379 Dunn, B.E., 1283, 1300 Galera, H., 1232 Hasebe, T., 401 Duray, P.H., 233 Gallagher, G., 105 Hasegawa, T., 257, 726 Gallo, P., 1078 Hashiguchi, Y., 988 Gamboa, J.D.M., 149 Hashimoto, H., 1116 Gamboa-Dominguez, A., 1252 Hassner, A., 803 kI BLE, J.N., 513, 590 Gannon, F.H., 842 Hauser, R., 36 Egensperger, R., 1136 Garb, J., 1344 Hayashi, N., 757 Eisenthal, A., 803 Garcia, A., 569 Hayashi, Y., 901, 1071 El-Bahrawy, M.A., 1216 Garrido, M., 1197 Heidebrecht, H.-J., 311 Elliott, D.J., 36 Gascon, J., 1023 Heidorn, K., 605 Ely, S.A., 339 Gasparini, R., 1344 Heimburger, D.C., 856 Emilie, D., 320 Gaulard, P., 196 Heitmuller, R.F., 447 Endrizzi, J].M., 630 Gazdar, A.F., 169, 753 Hejmanowski, A.Q., 521 Eng, ¢ Gebhard, S., 105 Helfenstein, A., 605 Enzan, H., 107] Geller, S.A., 665 Henrique, R., 487 Epistolato, M.C., 1003 Gerald, W., 537 Henry, M.D., 791 Epstein, J.I., 74, 81, 389, 417, 494, 506, Gerhard, D.S., 475 Herrera-Goepfert, R., 31 630, 997, 1141, 1209, 1278, 1417 Gerridzen, R., 434 Herring, R.F., 1309 Esposito, I., 1174 Gerschenson, L.E., 1029 Herrington, C.S., 1351 Esumi, H., 1043 Gersell, D.J., 475 Hill, D.A., 156 Etzel, [.E.; 222, 292 Geske, FJ., 1029 Hirabayashi, J., 302 1424 AUTHOR INDEX Hirai, K., 1064 Johnson, M.H., 74, 81, 1278, 1417 Klemen, H., 333 Hiraoka, K., 410 Jonat, W., 605 Knapik, J., 884 Hirohashi, S., 257, 834 Jones, E.C., 74, 101, 513 Knudsen, K.A., 149 Hiroi, M., 1071 Jones, J., 615 Ko, Y.-H., 954 Hiroi, S., 188 Jones, M.K., 178 Kobayashi, K., 1064 Hisaki, R., 237 Joo, M., 250 Kobori, K., 887 Hisaoka, M., 1116 Jordan, J.-H., 545 Kocher, O., 1269 Ho, L.T., 205 Josephson, M., 205 Kodama, H., 887 Hoang, M.P., 753 Juan, M., 227 Komiya, S., 410 Honda, K., 352 Judkins, A.R., 240 Kondo, K., 1064 Honda, Y., 1225 Jundt, G., 105 Kono, N., 302 Hongyo, T., 1403 Jurecka, W., 545 Koss, L.G., 615 Horie, T., 237 Kosuge, T., 834 Horny, H.-P., 545 Koukoulis, G.K., 823, 899, 1356 Hosaka, M., 1064 Kapin, M.E., 1269 Kovacs, G., 101 Hoshii, Y., 237 Kahn, H.]J., 50 Kronz, J.D., 389 Hoshino, Y., 757 Kallakury, B.V.S., 849 Krupinski, E.A., 1283 Hruban, R.H., 638 Krupp, G., 605 Kambham, N., 734 Hu, H., 42 Kamiya, K., 348 Kulthanan, K., 741 Huang, A.-C., 1240 Kanai, Y., 834 Kumaki, F., 188 HHuuhe,t tJn.e,r ,9 54P .C., 475 Kanavaros, P., 196 Kumar, K., 1147 Kanda, H., 1116 Kumon, Y., 910 HHuuim,p hAr.-eMy.,, 7P7.1A ., 74, 935, 1102, 1109 Kaneko, S., 1064 Kuno, K., 132 Kang, Y.K., 250 Kuo, L.H., 500 Hunt, J.A., 894 Hunt, J.L., 1020 Kanmatsuse, K., 237 Kurisu, K., 970 Kant, J.A., 677 Kuroda, N., 1071 Husain, A.N., 506 Kapadia, I., 1318 Kusano, M., 348 Huston, D.P., 346 Kutok, J.L., 1382 Kaplan, F.S., 842 Hutchins, G.M., 55; Kappeler, A., 1174 Kuzushima, K., 757 Hwang, E.S., 222 Karademir, S., 823 Kwong, Y.L., 126 Karahuseyinoglu, E., Karnovsky, M.J., 459 IBANEZ, C., 500 Kasai, K., 302 LABONTE, S., 230 Icard, P., 129 Kashani, A.H., 553 Lagarda, H., 569 Iglseder, B., 1136 Kashima, K., 352 Lar, R., E32 Hjiri, R., 880, 1012 Kasuga, M., 910 Lakari, E., 1257 Ikawa, H., 910 Kato, K., 880, 1012 Lalinga, A.V., 1003 Ikeda, M., 880 Kato, N., 796 Lam, €.C.K., 126 Imamura, T., 1116 Kato, S., 410 Lamant, L., 95 Inai, K., 970, 1203 Kato, Y., 1012, 1064 Lamps, L.W., 368, 379 Inayama, Y., 1064 Katoh, R., 10 ane, C.G., 74, 81, 1278, 1417 Indurkhya, A., 1147 Kattan, M.W., 828 ane, R.B., 74, 81, 1278, 1417 Inoue, K., 1071 Katzenstein, A.-L.A., aantuéjoul, S., 918 Inoue, T., 988 Kawai, T., 188 arue, H., 230 Irie, H., 887 Kawakami, S., 1064 askin, W.B., 704, 715, 745 Irie, K., 410 Kawanami, O., 1050 aucirica, R., 113 Ishida, T., 1116 Kawaoi, A., 10 aurent, P., 320 Ishihara, A., 1225 Kawasaki, H., 1043 aauwers, G.Y., 368, 379 Ishii, T., 242 Kayser, K., 1283 vaverriére, M.-H., 918 Ishiko, O., 988 Kern, S.E., 638 aawson, A., 1334 Ishikura, H., 163 Khettry, U., 814 ppppfepeeeeeeettdtteddd at zee nby, A.J., 368, 379 Itakura, E., 1225 Kim, C,J., 623 Le Doussal, V., 105 Ito, Y., 880 Kim, C.W., 954 Leal, C., 487, 537 Itoh, H., 910 Kim, G.-M., 643 Lechevallier, E., 282 Ivanoviene, L., 1003 Kim, H.-I., 643 Lechner, K., 545 Iwamoto, Y., 1225, 1245 Kim, H.S., 250, 297 Lecksell, K., 997 Iwasaki, Y., 237 Kim, J.-H., 643 Lee, H.K., 250 Kim, M.-K., 643 Lee, H.S., 250 Kim, M.H., 623 Lee, J.-S., 643 Kim, S.H., 250 Lee, J.H., 250 JANG, J.J., 250 Kim, S.U., 643 Lée, |-Y.; 250 Janssen, N.M., 346 Kim, S.Y., 250 Lee, M.-C., 643 Jarboe, E., 119 Kim, W.H., 297 Lee, S.H., 250 Jarosz, B., 1304 Kimura, H., 757 Lee, S.S., 954 Jarry, A., 461 Kinnula, V.L., 1257 Leenutaphong, V., 741 Jeffery, R., 1216 Kinukawa, N., 237 Lehner, R., 119 Jenkins, R.L., 814 Kisagawa, H., 1012 Les, [-¥., 233 Jensen, D., 823 Kishida, T., 1064 Leone, O., 1078 Jensen, R.A., 785 Kitahara, Y., 237 Lerochais, ].P., 129 Jerome, K.R., 342 Klapper, W., 605 Leroy, K., 196 Jin, E., 1050 Kleeff, J., 1174 Lesauskaite, V., 1003 Jin, Y., 887 Kleiman, S.E., 36 Lespagnard, L., 135 Johanning, G.L., 856 Klein, E.A., 1392 Leteurtre, E., 274 Johl, J., 963 Kleinschmidt, I., 89 Levin, H.S., 1392 1425 HUMAN PATHOLOGY Volume 32, No. 12 (December 2001) Levy, B.K., 156 McNeal, J.E., 242, 441, 1142 Nakazato, M., 237 Lewin, D.N., 368, 379 McWilliams, G., 233 Nalesnik, M., 1334 Lewin, K.J., 247 Meehan, S.M., 205 Nalpas, B., 904 Lewis, J.E., 596 Meggetto, F., 95, 288 Nam, S.-C., 643 Lewis, W.D., 814 Menéndez, C., 1023 Nanba, I., 1012 Merino, M.]J., 233 Nandedkar, M.A., 1327 Li Meschis, L., 1407 Naruse, K., 107] 11, [-Q., $ Michels, J.-J., 105 Nash, J.R.G., 1154 La X. Middleton, L.P., 233 Nassar, G., 1125 Li : 3, 475, 940 Midulla, R., 1407 Naughton, C.K., 935 Lij ang, C., 1283 Miettinen, M., 704, 873, 976 Nebuloni, M., 1022 Libertino, J.A., 18 Miki, H., 945 Nelson, P.T., 663 Lifschitz-Mercer, B., 803 Milbrandt, J., 935 Nemori, R., 163 Lindner, B., 1136 Milchgrub, S., 169 Neri, E., 1003 Linehan, W.M., 233 Milord, R.A., 997 Newcomb, E.W., 808 izo0u,.1S., 1392 Minervini, M.I., 1334 Ng, I.0., 778 Liu, N., 57 Minimo, C., 4 Ng, M.H.L., 1016 LiVolsi, V.A., 351, 1140, 1413 Misonznik, F., 803 Nguyen, H., 1147 Ljung, B.M., 292 Misugi, K., 1012 Nguyen, T.U., 346 Lo, K.-W., 1016 Mittal, K., 984 Ninomiva, T., 910 Lobel, B., 1209 Miyagi, E., 10 Nishi, T., 1012 Loh, K.S., 42 Miyazaki, E., 1071 Nishisaka, T., 970 Lomakin, I., 1184 Miyazaki, K., 302 Nishiwaki, Y., 1043 Lopes, C., 487 Mohar, A., 31 Nistal, M., 763 Lopes, P., 487 Mohr, W., 241 Niveleau, A., 856 Lopez-Ferrer, A., Molina, T., 129 Nobukawa, B., 447 Lou, I.-U., 1240 Molinaro, A., 292 Noel, J.-C., 135 Lowe, D., 963 Molnar, P.P., 1021, 1414 Noumoff, J.S., 762 Luszcz, J., 1344 Monga, G., 656 Novelli, L., 529 Monteiro, P., 487 Nuovo, G,]J., 216 Montgomery, E., 368, 379 Morash, C., 434 Ma, E.S.K., 126 Morgan, J., 750 Machin, P., 569 O'Leary, T.J., 578, 1309, 1318, 1323 Madelenat, P., 1190 Morishima, T., 7! O’Sullivan, M.J., 475, 1109 Magelli, C., 1078 Morrison, C.D., 2 Oberascher, G., 1136 Mai, K.T., 434 Morrow, J.S., 14: Obrist, P., 1264 Mosberger, I., 545 Maitra, A., 169, 753 Ochiai, A., 401 Majno, G., 898 Mosca, W., 149 Oda, Y., 1225, 1245 Moser, P., 1264 Makuuchi, M., 771 Odze, R.D., 1087, 1157 Mosnier, J.-F., 1166 Man, C., 126 Oelschlager, D., 856 Mancuso, S., 4 Mosnier-Damet, M., 1166 Oghalai, ].S., 346 Motoyama, T., 796 Manegold, E., 559 Ogita, S., 988 Mangold, K.A., 74, 81, 1278, 1417 Mou, L., 57 Ogura, T., 1043 Moulinoux, J.-P., 1209 Mann, S., 113 Oh, R.R., 250 Mourey, L., 288 Manunta, A., 1209 Ohaki, Y., 1050 Manzotti, M., 1410 Mucci, N.R., 417, 690 Ohbayashi, C., 910 Mukai, K., 834 Marconi, S., 1344 Ohmori, M., 945 Mullick, F.G., 1309 Marcus, A., 57 Munoz, J., 569 Ohmori, S., 1363 Maresi, E., 1407 Ohori, M., 828 Mura, D., 698 Mariano, M., 500 Ohori, N.P., 1039 Murray, P.G., 963 Marino, B., 1078 Okada, K., 726 Marino, LR., 1334 Murry, C.E., 342 Okada, S., 1272 Murry, T.C., 240 Markowitz, G.S., 734 Okamoto, S., 1116 Marquette, C.H., 274 Okazaki, E., 796 Martin, J.L., 149 Ollayos, C.W., 1318, 1323 Maru, N., 828 NAEEM, R., 1344 Olsen, K.D., 596 Masciullo, V., 4, 360 Nagahara, N., 1012 Olson, S.J., 487, 785 Massarelli, G., 698 Nagai, J., 1012 Olsson, H., 31] Massi, D., 360 Nagai, K., 1043 Onida, A., 698 Massi, G., 360 Nagano, H., 910 Ono, L., 796 Massip, P., 288 Nagasaka, T., 132, 757 Ono, M., 401 Matias-Guiu, X., 569, 1416 Nagashima, M., 1050 Onuma, K., 880 Matsumoto, K., 796 Nagashima, Y., 880, 1064, 1272 Ordi, J., 1023 Matsuno, Y., 257 Nagata, K., 410 Orjuela, M., 537 Maymon, B.B.-S., 36 Nagura, S., 10 Orlando, E., 1407 Mazzarol, G., 1410 Nakaji, M., 910 Orlicky, D., 119 Mazzucco, G., 656 Nakano, T., 1203, 1363 Orlow, I., 537 McCarthy, D.M., 638 Nakanuma, Y., 302 Ormsby, A.H., 1392 McCredie, M.R.E., 590 Nakasato, Y., 887 Oshiro, Y., 1225, 1245 McCue, P.A., 1027 Nakashima, H., 1272 Ostrowski, M.L., 863 McDicken, I.W., 1351 Nakashima, N., 132 Otis, C.N., 1344 McGregor, D.K., 346 Nakashima, T., 132 Ottoveggio, G., 1407 McKeon, F.D., 479, 1157 Nakayama, I., 352 Ozden, O., 745 McMahon, J.T., 649 Nakayori, F., 1203 Ozeki, Y., 188 1426 AUTHOR INDEX PAAKKO, P., 1257 RADER, J.S., 475 Sepulveda, A.R., 698 Pacchioni, D., 468 Ragni, M.V., 963 Sesterhenn, I.A., 74 Page, D.L., 487, 785 Ramee, M.-P., 1209 Sethi, S., 660 Paglierani, M., 360, 529 Ramesh, H., 1174 Shah, R.N., 745 Palazzo, J.P., 24, 769 Randhawa, P., 1334, 1388 Shahsafaei, A., 1157 Pallotti, F., 1022 Rao, S., 745 Shaikh, A.A., 389 Palmerini, F., 461 Rathor, S., 884 Sharma, A., 1059 Pan, C.C., 494 Realdi, G., 698 Shaw, H., 428 Pan, X., 1050 Recla, D.L., 1300 Sheehan, C.E., 849 Papadimitriou, J.C., 894 Ree, H.]., 954 Sheen, T.-S., 1240 Papierz, W., 1304 Reichenbach, D.D. Shen, J., 823, 1356 Papotti, M., 918 Remotti, F., 873 Shi, ¥.-Z., 771 Papp, A.C., 521 Renner, H., 333 Paradis, V., 327 Rennke, H.G., 660 Shibata, M., 163 Park, J.K., 250 Reusche, E., 1136 Shibuya, M., 10 Park, S.-S., 623 Reuter, V.E., 74 Shieh, W.-J., 750 Park, S.H., 297 Ribera, M., 227 Shiga, J., 887 Park, W.S., 250 Richter, L., 1283 Shimada, K., 834 Parmigiani, G., 417 Ridaura, C., 537 Shimajiri, S., 1116 ParsonnetJ,. , 31 Rieger-Christ, K.M., 18 Shimizu, H., 1050 Parwani, A.V., 506 Rioux-LeClercq, N., 1209 Shimizu, Y., 348 Parwaresch, R., 311, 605, 1376 Ripley, D., 884 Shimoda, T., 257 Pasquali, C., 1094 Ro, J.Y., 863 Shimonishi, T., 302 Passantino, R., 1407 Robert, M.E., 368, 379 Shin, M.S., 250 Patard, J.-J., 1209 Rosai, J., 352 Shinomiya, N., 188 Paz, G., 36 Rosenberg, E., 808 Shiraki, K., 1363 Peek, R.M. Jr., 264 Rosenthal, D.L., 1318 Shivapurkar, N., 169 Pellegrinelli, A., 1022 Ross, C.W., 66 Shore, E.M., 842 Perez-Perez, G.I., 264 Ross, J.S., 849 Shrikhande, S., 1174 Perlman, E.J., 1109 Rosser, R.J., 1416 Shroyer, K.R., 119 Rothstein, J.L., 24 Perry, A., 156, 1102 Shuin, T., 1071 Rubin, M.A., 417, 690 Pesti, T., 101 Shyr, Y., 264, 368 Rudolph, P., 311, 605, 1376 Peterson, L., 745 Sichez, H., 282 Petit, B., 196 Sieben, N.L., 1416 Petrovic, L.M., 1371 Silva, M.d.A., 487 Pettay, J.D., 1392 Silverman, M.L., 18 Petzmann, S., 333, 1059 SasiT, H., 302 Simpson, J.F., 785 Pfeifer, J.D., 1102, 1109 Sadhu, A., 205 Sinard, J.H., 143 Piard, F., 320 Saito, F., 237 Singleton, T.P., 66 Pienta, K.J., 690 Saitoh, N., 401 Skacel, M., 1392 Pierson, C.R., 513 Sakai, N., 1064 Sobonya, R.E., 669 Pietarinen-Runtti, P., 1257 Sakai, T., 1363 Soini, Y., 1257 Pilz, P., 1136 Sakamaki, T., 25 Pinkus, G.S., 1382 Sakamoto, A., Soler, A.P., 149 Piyathilake, C.J., 856 Sakamoto, M., 83 Somerhausen, N.d.S.A., 105 PPiozlz,i , S.S,. ,9 0140 94 SSaaklra,z arW,. ,A .,7 4 537 SSoorriecnh,s enJ,., 8P0.8H. B., 513 Samel, A., 1269 Southern, S.A., 1351 Polizzotti, G., 1022 Polyvkin, N., 803 Sanchez, L., 31 Spark, R.P., 1142 Sanders, M.E., 1276 Sperr, W.R., 545 Pomfret, E., 814 Sangruchi, T., 741 Speyer, J.L., 808 Pommier, R.F., 178 PomposellJi.,J. , 814 Santini, D., 4 Spina, D., 1003 Sarkar, F.H., 513 Srigley, J.R., 513 Ponce-Castaneda, M.V., 537 Poncelet, C., 1190 Sasaki, S., 401 Srivastava, A., 1184 Pons, C., 569 Sassi, C., 1003 Stadlmann, S., 1264 Popper, H.H., 333, 863, 1059 Savici, D., 1398 Stewart, J.H., 590 Porchet, N., 274 Scambia, G., 4, 360 Stoolman, L.M., 66 Porte, H., 274 Scanlan, R.M., 178 Sturm, N., 918 Poulet, B., 904 Scardino, P.T., 828 Sugimoto, K., 1363 Poulsom, R., 1216 Schmidt, W.A., 178 Sugitoh, M., 401 Powell, S., 863 Schnell, C.S., 963 Sugiyama, K., 970 Prasopchoke, P., 741 Schnitzer, B., 66 Suh, J.-J., 643 Schober, M.S., 513 Prat, J., 569, 1416 Schoenberg, M.P., 630 Suki, W.N., 1125 Prayson, R.A., 649 ScholesJ,. , 396 Sukosd, F., 101 Prior, T.W., 521 Schreiber, L., 36 Sukpanichnant, S., 741 Pruneri, G., 1410 Summerhayes, I.C., 18 Schréder, W., 559 Puig, L., 227 Schubert, C., 1376 Sun, D., 479 Pylkas, P., 1257 Scoazec, J.-Y., 1190 Suno, A., 656 Scott, K.M., 1283 Susini, T., 360 Seay, T.M., 630 Suster, S., 352 Sebo, T.J., 596 Swalsky, P.A., 1039 Qin, L., 778 Sehdev, A.E.S., 494 Swinnen, L.J., 963 Quade, B.J., 479 Seo, Y., 910 Szymus, J., 1283, 1304 1427 HUMAN PATHOLOGY Volume 32, No. 12 (December 2001) Tappel, G.L., 360 Tuneyama, K., 302 XERRI, L., 461 Taguchi, K., 1272 Turlin, B., 1209 Xiong, Y., 149 Takahashi, I., 887 Au, JL. 757 Takase, K., 1363 Takayama, T., 771 Takemura, T., 1050 ULLMANN, R., 333, 1059 YACHNIS, A.T., 884 Takeshima, Y., 970, 1203 Yagi, H., 237 Takimoto, M., 348 Yagi, Y., 1334 Talbot, I., 1216 Yamamoto, K., 988 T ‘alerman, A., 884 VALENT, P., 545 Yanagawa, Y., 887 I‘ amiya, S., 1225, 1245 Vatanavicharn, S., 741 Yang, A., 479, 1157 I an, 1.K-S.--42 Velasquez, J.N., 500 Yang, W.I., 954 |a n. S.Y.- 42 Verhest, A., 135 Yang, Y., 57 I anaka, N., 757 Vetto, J.T., 178 Yang, Y.-C., 479 I‘ anaka, Y., 880, 1012 Viale, G., 1410 Yano, H., 410 T ‘ang, K.F., 42 Vince, D.R., 105 Yano, Y., 910 I‘ anganelli, P., 1003 Virtanen, I., 1356 Yao, M., 1064, 1272 I‘ anji, K., 734 Volante, M., 468 Yavetz, H., 36 I‘ anji, N., 734 Yee, H., 808 I‘ appero, J.W., Yeldandi, A., 745 Tavassoli, F.A., 71! Yeo, C.J., 638 Fellado, M.V., 1323 WacayaMa, H., 1363 Yogev, L., 36 Perrier, P., 105 Wagner, B.M., 1278 Yokose, T., 1043 Terzano, P., 4 Walchshofer, S., 545 Yokoyama, R., 257, 726 Tétu, B., 230 Waldman, F.M., 222, 299 Yokoyama, S., 352 Tham, K.T., 264 Walker, F., 1190 Yoo, N.J., 250 Wallis, T., 513 Thistlethwaite, J.R., 205 Yoon, B.H., 623 Thompson, L.D., 842, 1318 Walsh, M.M., 583 Yoon, S., 910 Thor, A., 222 Walsh, N.M.G., 680 Yoshida, M., 1064, 1272 Thurmond, A., 178 Wan, T., 126 Yoshikawa, T., 887 Wang, T.-Y., 479 Tietze, L., 559 Yoshiki, T., 163 Wang, Y., 479 Tizzani, A., 468 Younes, A., 113, 940 Washington, K., 368, 379 Toi, M., 1071 Younes, M., 113, 940 Toledano, A.Y., 368 Watanabe, T., 237 - Younes, P.S., 113 Toomey, S.M., 963 Weinstein, R.S., 1, 669, 1283, 1304 Young, L.S., 963 Torbenson, M., 1388 Weiss, H., 856 Yousem, S.A., 428, 1039 Torikata, C., 188 Werner, A., 339 Youssef, N., 327 Tosi, D., 1022 West, K.P., 1154 Yutani, C., 237 Wheeler, T.M., 74, 417, 828 Toyoda, Y., 880, 1012 Wilentz, R.E., 638 Trassard, M., 105 Trinka, E., 1136 Wilkinson, E.J., 884 ZAHURAK, M.L., 379 Trinkaus, K.M., 475 WWiilllliaimasm, sJ,.B .,H .8,2 3 1309, 1318, 1323, 1327 ZZaakmip,a rSe.lRl.i, , 75A0., 4 TTrrounocnogs,o , L.DP..,, 7141 25 Witte, D., 940 Zattara-Cannoni, H., 282 Tsang, K.-S., 1016 WWoollff,e , G.H,. J.1,3 041 232 ZZeelnemnyiou,c h-JM.a,c qu4o1t0t e, A., 808 Tsao, M.-S., 57 Wolff, K., 545 Zimmermann, A., 1174 Tsiftsakis, E.K., 1392 Wong, N., 1016 Zippe, C.D., 1392 Tsuda, H., 988 Woo, Y.-J., 643 Zitella, A., 468 Tsuneyoshi, M., 1225, 1245 Wu, F., 945 Zoppi, L.B., 149 Tsunoda, A., 348 Wu, M.L., 247 Zorini, E.O., 656 Tsunoda, Y., 348 Wu, T., 1334 Zou, W., 320 Tubbs, R.R., 1392 Wu, T.-T., 447, Zylberberg, H., 904 Index of Subjects for Volume 32 The following is a list of page numbers according to issue pulmonary for Volume 32 (2001) of HUMAN PATHOLOGY: and synchronous extranodal marginal zone/low-grade B-cell lymphoma, 129-132 HRES RAR YPEa ce retest, swcsyastiesSevcastastackeeeeteh aeteasanstialdiaacese s ; markers to differentiate pleural epithelial mesothelioma from, 529-536 February . 143-246 urinary bladder, primary and secondary prostatic, 434-440 March 247-356 Adenoid cystic carcinoma April . 357-458 dedifferentiation of, 1403-1407 May ... 459-566 Adenoma June 567-668 adrenal cortical, proliferative, microvessel network in, 1232-1239 July 669-768 colorectal, deletions of chromosome 4 in pathogenesis of, 169- August 769-898 177 September 899-1026 intrathyroidal water-clear cell parathyroid, 889-892 October 1027-1146 metanephric, chromosome 2p13 in, 101-104 Adenoma-carcinoma sequence, in colon cancer 1147-1282 survivin expression in normal, hyperplastic, and neoplastic co- 1283-1446 lonic mucosa, 119-125 Adenomatous polyposis coli (APC) gene in nasopharyngeal angiofibroma (Correspondence), 455 Adhesion molecules ACOUSTIC NEUROMA expression in CD5—/CD10— chronic B-cell leukemias, 66-73 subacute fatal aluminum encephalopathy after surgery for, 1136- neural cell, overexpression of in Chagas’ myocarditis, 149-155 1140 Adhesion proteins Acquired (digital) fibrokeratoma co-downregulation of, in prostatic adenocarcinoma, 849-855 vs. supreficial acral fibromyxoma, 704-714 Adrenal cortex Acquired immunodeficiency syndrome (AIDS) proliferative lesions of, microvessel network in, 1232-1239 apoptosis and, 1034 Adrenal gland human herpesvirus-8 in bone marrow biopsies of HIV-positive Ewing’s sarcoma family of tumor arising in, 1012-1016 patients, 288-29] Age isosporosis and unizoite tissue cysts in, 500-505 and Helicobacter genotypes in peptic ulcer disease, 264-273 Acral fibromyxoma AgNOR, see Silver-staining nucleolar organizer region superficial, 704-714 Allelic losses Acral myxoinflammatory fibroblastic sarcoma, 704-714 in short- vs. long-segment Barrett esophagus, 447-454 Acral pseudolymphomatous angiokeratoma Allelotyping cutaneous lymphocyte antigen expression in, 227-229 loss of heterozygosity at 11q23.3 in squamous cell carcinoma of Acute promyelocytic leukemia cervix, 475-478 therapy-related myelodysplastic syndrome after, 126-129 Allograft, renal Acute respiratory distress syndrome (ARDS) arcuate and interlobular phlebitis in, 1388-1391 diffuse alveolar damage and, 1398-1402 plasmacytic infiltrates in percutaneous biopsies of, 205-215 Acute tubular necrosis polyomavirus BKV strain in recipient of, 656-659 adefovir nephrotoxicity leading to, 734-740 post-transplant lymphoma in hypopharynx of recipient, 1264- Adefovir 1268 nephrotoxicity of, role of mitochondrial DNA depletion, 734-740 Aluminum Adenocarcinoma subacute fatal encephalopathy after reconstructive neurosurgery, Barrett esophagus 1136-1140 dysplasia as predictive marker for, 379-388 Alveolar capillary endothelium early, in short- vs. long-segment, 447-454 remodeling of, with aerogenous spread of primary lung adeno- bronchioloalveolar, absence of Jaagsiekte sheep retrovirus in, carcinoma, 1050-1058 1039-1042 Alzheimer’s disease colonic, survivin expression in, 119-125 apoptosis and, 1034 colorectal American Board of Pathology (ABP) deletions of chromosome 4 in pathogenesis of, 169-177 accredited programs and persons certified by, 671-673 estrogen receptor B in, 940-944 Ammon horn sclerosis endometrial, Rb2/p130 expression in, 360-367 in temporal lobe epilepsy, 643-648 endometrioid, high telomerase activity in, 605-614 Ampulla of Vater lung, primary carcinoid tumors of, 1252-1256 aerogenous spread of, and alveolar capillary remodeling, 1050- Amyloidosis 1058 late-onset cardiac, with new transthyretin variant, 237-239 pattern of mucin gene expression in, 274-281 localized, and extramedullary plasmacytoma of larynx in child, pancreatic 132-134 infiltrating, DPC4 in, 638-642 subcutaneous nodular, 346-348 Nr-CAM expression in, 396-400 Anaplastic lymphoma kinase (ALK) immunostaining prostatic and 2p23 in pulmonary inflammatory pseudotumors, 428-433 cell adhesion proteins in, 849-855 Anaplastic meningioma comparison of sampling methods for nonpalpable, 494-499 immunohistochemical study of, 970-975 cytologic criteria in histologic diagnosis of Gleason grade 1, Anatomic pathology 441-446, 1141-1142 (Correspondence) informatics and (Editorial), 143-148 E-cadherin in, tissue microarray technology in, 690-697 teaching of, in England and Wales (Editorial Comment), 11541 156 1429 HUMAN PATHOLOGY Volume 32, No. 12 (December 2001) Anencephaly Atomic absorption spectrometry meningeal-cutaneous relationships in, 553-558 aluminum encephalopathy after reconstructive otoneurosurgery, Aneurysm 1136-1140 dialtative pathology of thoracic aorta, 1003-1011 Atrophy ruptured coronary, sudden infant death caused by, 1407-1409 gastric, in Helicobacter pylor-infected patients, 31-35 Angiocentric lymphoproliferative lesion Atypical ductal hyperplasia orbital, with immature natural killer cell immunophenotype, 339- perineural invasion of breast by, 785-790 Atypical endometrial hyperplasia 342 Angiocentric T-cell lymphoma comparative genomic hybridization of endometrioid carcinoma and, 615-622 of pancreas, presenting as diabetes mellitus, 741-745 Rb2/p130 gene expression in, 360-367 Angiofibroma Atypical fibroxanthoma nasopharyngeal, lack of APC gene alterations in, 455 (Corre- H-, K-, and N-ras mutations in, 1225-1231 spondence) Atypical teratoid/rhabdoid tumors Angiogenesis chromosome 22q dosage in, vs. medulloblastoma/central primi- and CD34 expression in chronic liver disease, 1363-1370 tive neuroectodermal tumors, 156-162 Angiokeratoma, acral pseudolymphomatous Autoimmune disorders cutaneous lymphocyte antigen expression in, 227-229 Graves disease, vascular endothelial growth factor in, 10-17 Angiotensin-converting enzyme gene Autonomic nerve tumor, gastrointestinal polymorphism of, in pulmonary fibrosis, 521-528 protein tau in, 1166-1173 Antigen retrieval Axillary skin biopsy Antigen Retrieval Techniques: Immunohistochemistry and Molecular Mor- ultrastructural examination of, in diagnosis of metabolic diseases, phology (book review], 351 649-655 Antioxidants Azoospermia, nonobstructive hemeoxygenase 1, in healthy lung and interstitial lung disorders, RNA-binding motif (RBM) antibody in testicular biopsies of men 1257-1263 with, 36-41 Antiviral agents adefovir, nephrotoxicity of, 734-740 Aorta B CELLS medial calcification of, 241-242 (Correspondence) in epithelial and perivascular compartments of adult thymus, Aorta, thoracic 926-934 smooth muscle cells of media in dilatative pathology of, 1003- B-cell lymphomas 1011 Bcl-6 and CD10 coexpression in diffuse large, 954-962 Apocrine ductal carcinoma Barrett esophagus in situ, of breast, histologic classification and markers, 487-493 dysplasia as predictive marker for invasive carcinoma, 379-388 Apoptosis high-grade dysplasia and early adenocarcinoma in short- vs. long- biology of, 1029-1038 segment, 447-454 AIDS and, 1034 more steps forward (Editorial), 357-359 Alzheimer’s disease and, 1034 classification of dysplasia in, 357-358 apoptotic regulation, 1032-1034 clinical relevance of grading, 358 cell membrane changes, i031 definition disease and, 1034-1035 reproducibility of grading of dysplasia, 358 heart disease and, 1034 short- versus long-segment, 359 history, 1029-1030 p63 expression in, 1157-1165 mitochondrial changes, 1031 reproducibility of diagnosis of dysplasia in, 368-378 modulating therapies, 1035 Basaloid carcinoma multiple sclerosis and, 1034 of lung, thyroid transcription factor 1 and cytokeratin expression nuclear changes, 1039-1031 in, 918-925 proteolytic changes, 1031-1032 Basement membrane cardiomyocyte apoptotic bodies, thanatosomes and, 894-895 dystroglycan in breast and prostate cancer, 791-795 (Correspondence) Bcl-2 caspase 7 downregulation as marker of colon carcinoma, 461-467 in biology of apoptosis, 1029-1038 cholangiocytic, in chronic ductopenic rejection, 823-827 Bel-6 dilatative pathology of thoracic aorta, 1003-1011 and CD10 in diffuse large B-cell lymphomas, 954-962 Bcl-x, microvessel network in adrenal cortical proliferative lesions, in bone marrow mast cells in systemic mastocytosis, 545 1232-1239 Bile ducts, intrahepatic of Fas in hepatocellular carcinoma, 250-256 cholangiocytic apoptosis in chronic ductopenic rejection, 823- survivin expression in normal, hyperplastic, and neoplastic co- 827 lonic mucosa, 119-125 endogenous galectins in intrahepatic cholangiocarcinoma, 302- Arcuate vein 310 phlebitis in, in renal allografts, 1388-1391 Biliary epithelial dysplasia Armed Forces Institute of Pathology (AFIP) endogenous galectins in intrahepatic cholangiocarinoma, 302- international static image-based telepathology service, 1309-1317 310 telecytology diagnosis of cervical-vaginal smears, 1318-1322 Bioartificial liver telecytology consultation service, characteristics of, 1323-1326 activation of hepatic stellate cells after treatment with, 1371-1375 telehematopathology in clinical consultative practice, 1327-1333 Biologic markers Aromatase of apocrine ductal carcinoma in situ of breast, 487-493 in fine-needle aspirates of breast carcinomas, 348-351 Biopsies Arrhythmogenic right ventricular cardiomyopathy bladder, correlation of cystoscopy with histologic diagnosis, 630- pathologic patterns in, 1078-1086 637 Artifacts bone marrow polymerase chain reaction, in microdissected specimens, 1415- human herpesvirus-8 in HIV-positive patients, 288-291 1416 liver, in chronic hepatitis C (Editorial), 899-903 1430 SUBJECT INDEX prostate Cadherin, E- high-grade prostatic intraepithelial neoplasia with small atypi- co-downregulation of, in prostatic adenocarcinoma, 849-855 cal glands,389-95 in prostate cancer, tissue microarray technology in, 690-697 renal allograft, percutaneous, plasmacytic infiltrates in, 205-215 in sporadic colorectal carcinoma, 1216-1224 renal, in nonlupus nephritides in systemic lupus erythematosus, Cadherins 1125-1135 type I, in urothelial neoplastic progression, 18-23 testicular Calcification RNA-binding motif (RBM) antibody in, in infertile men, 36-41 medial, of the aorta (Correspondence), 241-242 Bladder, urinary Calretinin cadherins type I in urothelial neoplastic progression, 18-23 marker for pleural epithelial mesothelioma, 529-536 cytoscopic impression and histologic diagnosis of biopsy speci- Carcinoembryonic antigen (CEA) mens, 630-637 as negative marker for pleural epithelial mesothelioma, 529-536 flat urothelial carcinoma in situ, diagnosis of, 997-1002 Carcinogenesis primary and secondary prostatic adenocarcinoma of, 434-440 gallbladder, reduced p21““F!/C?! expression in, 771-777 progression from superficial to invasive carcinoma, 468-474 Carcinoids Bone marrow lung, loss of heterozygosity on 11q in, 333-338 mast cells, typing of in systemic mastocytosis, 545-552 of duodenum and ampulla of Vater, 1252-1256 Bone marrow biopsies Carcinoma human herpesvirus-8 in, from HIV-positive patients, 288-291 adenoid cystic, dedifferentiation of, 1403-1407 Bone tumors basaloid and large-cell neuroendocrine, of lung, 918-925 rosette-forming epithelioid osteosarcoma, 726-733 bladder, progression from superficial to invasive, 468-474 Book reviews breast Barlett: Ovarian Carcinoma—Methods and Protocols, 762-763 aromatase in fine-needle aspirates, 348-351 Carpenter & Karpati: Pathology of Skeletal Muscle, 1277 ductal, cyclin E expression in, 89-94 Craighead: Pathology and Pathogenesis of Human Viral Disease, 1413- invasive micropapillary, 583-589 1414 lobular in situ, loss of chromosome 16q in, 292-296 Crawford: The Invisible Enemy: A Natural History of Viruses, 892-894 tubular, genomic alterations in, 222-226 Fajardo et al: Radiation Pathology, 1140-1141 tyrosine kinase activation in, 1344-1350 Fletcher: Diagnostic Histopathology of Tumors, 1021-1022 cervical Fu et al: Head and Neck Pathology with Clinical Correlates, 1140 p53 homologue p63 expression in, 479-486 Killeen: Molecular Pathology Protocols, 1020-1021 squamous cell, loss of heterozygosity at, 11q23.3 in, 476-478 Klatt & Kumar: Robbins Review of Pathology, 240-241 colon McLendon et al: Pathology of Tumors of the Central Nervous System, caspase 7 downregulation as marker of, 461-467 663-664 colorectal Mydlo: Renal Cancer, Methods and Protocols, 1276-1277 cyclin E and cyclin-dependent kinase 2, in, 945-953 Prayson & Cohen: Practical Differential Diagnosis in Surgical Neuro- E-cadherin and catenins in sporadic, 1216-1224 pathology, 240 deletions of chromosome 4 early in pathogenesis of, 169-177 Shi, Gu, & Taylor: Antigen Retrieval Techniques: Immunohistochemis- proliferative activity as predictor of metastasis in, 401-409 try and Molecular Morphology, 351 endometrial Weiss & Goldblum: Enzinger and Weiss’s Soft Tissue Tumors, 1414 molecular pathology of hyperplasia and, 569-577 Brain tumors transitional cell, with a benign ovarian Brenner tumor, 230-232 immunohistochemical study of benign, atypical, and anaplastic gallbladder meningiomas, 970-975 oa CIP1 in, 7 Breast hepatocellular female, lymph nodes in, 178-187 Fas and Fas-related molecule expression in, 250-256 Breast cancer genomic instability in, 698-703 cyclin E expression in ductal carcinoma, 89-94 p27! and p21““F!/ClP! in, 778-784 ductal carcinoma in situ (DCIS) CD34-positive sinusoidal endothelial cells as risk factor for, apocrine, histologic classification and markers, 487-493 1363-1370 perineural invasion by atypical ductal hyperplasia and, 785-790 keratin 1 expression in, 873-879 dystroglycan, reduced expression in, 791-795 lung estrogen receptor beta expression in invasive, 113-118 telomerase expression and activity in, 188-195 genomic alterations in tubular, 222-226 nasopharyngeal invasive micropapillary carcinoma, 583-589 multidrug resistance protein 1 and glutathione-S-transferase-7 lobular carcinoma in situ, loss of chromosome 16q, in, 292-296 in, 1240-1244 p53, c-erbB, and the cell cycle in node-negative, 311-319 CC chemokine expression in, 42-49 primary mammary small-cell carcinoma, molecular analysis of, neuroendocrine, of skin, morphologic diversity of, 680-689 753-757 odontogenic, pigmented intraosseous, of maxilla, 880-884 tyrosine kinase activation in, 1344-1350 pancreatic with aromatase in fine-needle aspirates, 348-351 intraductal papillary components of, 834-841 Brenner tumor prostate benign ovarian, with transitional cell carcinoma of endometrium, perineural invasion in, 828-833 230-232 Gleason score 7, genetic changes in, 1392-1397 Bronchioloalveolar carcinomas Gleason grading, interobserver reproducibility, 74-80, 81-88 absence of Jaagsiekte sheep retrovirus DNA and RNA in, 1039- loss of EGR1 corepressor NAB2 in, 935-939 1042 renal cell mucinous, mucin gene expression pattern in, 274-281 CD9/motility-related protein 1 in papillary and chromophobe, 1071-1077 cell proliferation, microvessel density, and CD44 in, 1209-1215 C-ERBB-2 genetic markers in (Editorial), 1027-1028 as marker for apocrine ductal carcinoma in situ of breast, 487- papillary, morphologic typing of, 590-595 493 pigmented clear cell, with melanocytic differentiation, 233-236 overexpression of p53 and, in node-negative breast cancer, 311- SPARC expression in, 1064-1070 319 subtypes of, Pax-2 expression in, 282-287 HUMAN PATHOLOGY Volume 32, No. 12 (December 2001) thyroid Central nervous system tumors papillary, Hashimoto’s-associated, 24-30 atypical teratoid/rhabdoid tumor, chromosome 22q dosage in, vulvar 156-162 squamous cell, pRB2/p130 and a in, 49 Pathology of Tumors of the Central Nervous System [book review], ‘arcinoma cells 663-664 hepatocyte growth factor expression by, in non-small cell lung Cervix, uterine cancer, 57-65 cervical-vaginal smears, telepathology system for, diagnosis of, ‘arcinoma ex pleomorphic adenoma 1218-1322 pathologic analysis of, 596-604 loss of heterozygosity at 11q23.3 in squamous cell carcinoma of, Jarcinoma in situ 475-478 flat urothelial, diagnostic aid for, 997-1002 lymphoepithelioma-like carcinoma of, human papillomavirus ‘ardiac amyloidosis and, 135-138 late-onset, with new transthyretin, 237-239 MUC4 expression in dysplastic disorders of, 1197-1202 ‘ardiomyocyte apoptotic bodies p53 homologue p63 expression in, for classification of, 479-486 thanatosomes and (Correspondence), 894-895 squamous intraepithelial lesions of, cytokeratin 1, 4 and, 1351- ‘ardiomyopathy 1355 arrhythmogenic right ventricular, pathologic findings, 1078-1086 superficial cervicovaginal myofibroblastoma, 715-725 ‘aspase 7 Chagas’ myocarditis downregulation of, as marker of colon carcinoma, 461-467 overexpression of neural cell adhesion molecule in, 149-155 vaspases Chemokines in biology of apoptosis, 1029-1038 CG, expression of in nasopharyngeal carcinoma, 42-49 ‘astieman’s disease, multicentric RANTES, in pulmonary Wegener’s granulomatosis, 320-326 viral interleukin-6 and latent nuclear antigen-1 in lymphoid cells Children, see Pediatric pathology in, 95-100 Cholangiocarcinoma Jatenin, a- intrahepatic, endogenous galectin-1 and galectin-3, 302-310 co-downregulation of, in prostatic adenocarcinoma, 849-855 Cholangiocytic apoptosis ‘atenin, B- in chronic ductopenic rejection, 823-827 co-downregulation of, in prostatic adenocarcinoma, 849-855 Cholecystitis mutations in, in endometrial hyperplasia and carcinoma, 574-575 leptospirosis mimicking, in athletes at a triathalon, 750-752 prognostic significance of in synovial sarcoma, 257-263 Chondrosarcoma Catenins extraskeletal myxoid, 1116-1124 in sporadic colorectal carcinoma, 1216-1224 Chromophobe renal cell carcinoma 1C chemokines CD9/motility-related protein 1 in, 1071-1077 expression of by macrophages in nasopharyngeal car, cinoma, Chromosomal aberrations 42-49 pulmonary inflammatory pseudotumors, 2p23 in, 428-433 ‘D9 Chromosome 2p13 in papillary and chromophobe renal cell carcinomas, 1071-1077 in metanephric adenoma, 101-104 ‘D10 Chromosome 4 in diffuse large B-cell lymphomas, 954-962 deletion of early in pathogenesis of colorectal carcinoma, 169- 1D15 177 as negative marker for pleural epithelial mesothelioma, 529-536 Chromosome 9 D2 in progression of bladder carcinoma, 468-474 in bone marrow mast cells in systemic mastocytosis, 545-552 Chromosome 11q 1D34 loss of heterozygosity on, in lung carcinoids, 333-33 in renal cell carcinoma, 1209-1215 Chromosome 16q in sinusoidal endothelial cells, as risk factor for hepatocellular loss of, in lobular carcinoma in situ, 292-296 carcinoma, 1363-1370 Chromosome 22q vs. tenascin, for differentiation dermatofibroma from dermatofi- dosage in atypical teratoid/rhabdoid tumors, 156-162 brosarcoma protuberans, 50-56 in composite extrarenal rhabdoid tumors, 1102-1108 ‘D44 Chronic B-cell leukemia cell adhesion proteins in prostatic adenocarcinoma, 849-855 CD5—/CD10-—, adhesion molecule expression in, 66-73 in leiomyosarcoma diagnosis, 1190-1196 Chronic lymphocytic leukemia in renal cell carcinoma, 1209-1215 adhesion molecule expression in, compared with CD5—/CD10- 1D44H chronic B-cell leukemia, 66-73 markers for pleural epithelial mesothelioma, 529-536 Cirrhosis D117 genomic instability in chronic viral hepatitis and hepatocellular in gastrointestinal stromal tumor, 578-582 carcinoma, 698-703 CD117 (Kit) vitronectin as marker of mature fibrosis in, 1356-1362 in bone marrow mast cells in systemic mastocytosis, 545-552 Classic cadherins type I tell adhesion molecules in urothelial neoplastic progression, 18-23 Nr-CAM in hyperplastic and neoplastic pancreatic tissue, 396-400 Clear cell carcinoma Cell cycle histologic diagnosis of Gleason grade 1 prostatic adenocarci- accelerated, and poor prognosis in node-negative breast cancer, noma, 441-446 311-319 Clinical pathology Cell cycle regulators curricular trends in, nationwide survey, 1149-1150 alterations of in nonfamilial retinoblastoma, 537-544 Clinicopathologic analysis and survivial in epithelial ovarian tumors, 808-813 adult-to-adult live donor liver transplantation, 814-822 cyclin-dependent kinase inhibitors (Editorial), 769-770 extraskeletal myxoid chondrosarcoma, 1116-1124 repp86, and progression in endometrioid adenocarcinoma, 605- nonlupus nephritides in systemic lupus erythematosus, 1125-1135 614 of superficial acral fibromyxoma, 704-714 Cell cycle-associated proteins Clonality cyclin E expression in breast ductal carcinoma, 89-94 of adrenal cortical proliferative lesions, 1232-1239 pRB2/p130 and p27sP in vulvar squamous cell carcinoma, 49 of Hodgkin’s lymphoma of T-cell type, 1269-12 1432

ebook img

Human Pathology 2001: Vol 32 Index PDF

25 Pages·2001·6.2 MB·English
by  
#periodicals #sim_microfilm #pub_human-pathology
Save to my drive
Quick download
Download
Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Human Pathology 2001: Vol 32 Index

Index of Authors for Volume 32 ABBONDANZO, S.L., 1327 Bell, A., 734 Cai, Y.-C., 1087 Abdulkadir, S.A., 935 Bell, W.C., 856 Cain, J.W., 18 Abiko, Y., 880 Benhattar, J., 105 Cameron, J.L., 638 Abraham, S.C., 447, 455 Benigni, E., 656 Campbell, K-P., 791 Abramovich, C.M., 649 BenningtonJ,. , 222 Canavese, G., 1094 Abramson, D., 537 Bento, M.]., 487 Cannizzaro, L.A., 615 Addis, V.M., 521 Beranek, J.T., 894 ao ‘apron, F., 320 Adeyi, O.A., 660 Berman, J., 578 sarbone, J.M., 935 Adsay, V., 513 Bernardi, M., 656 varlson, N., 113 Aita, K., 887 Bethwaite, P.B., 590 varnevale, S., 500 Akalin, A., 889 Bhargava, R., 1344 varnot, F., 904 Akiyama, H., 237 Bhattacharyya, A.K., 1283 Jaron, R., 842 AAllbaomreedsa-,S aaFv.,e dr1a19,7 J., 753 Biegel, J.A., 884 tasetta, G., 468 Bildirici, K., 889 ‘astro, C.Y., 863 AAAllleeesxxsaaannndddeerrri,,n i,JC ..,B C..1,,1 861470 10 3 BBiilrogu, s,F .,A .4M6.1, 590 ARCasAAtaaAtRsaRlu osAn,a L, L .W,. ]5J.6,9 935 Alexander, P., 178 Blandenier de Suarez, C., 149 CCeecscaarremlalni,, CE..,, 945 , 288 Ali, N., 113 Blanes, A., 1232 Chadburn, A., 339 Alison, M.R., 1216 Blaser, M.J., 264 Chambonniére, M.-L., 1166 Allen, E.A., 1323 Bleiweiss, [.J., 583 Chan, J.K.C., 1403 Alli, P.M., 1318 Bobak, J., 119 Chan, S.H., 42 Allsbrook, W.C. Jr., 74, 81, 1278, 1417 Boddi, V., 529 Chan, T., 1209 Alm, P., 311 Boldorini, R., 656 Chanel, S., 129 Almagro, U.A., 1300 Bonatz, G., 605 Chang, M.S., 297 Alonso, P.L., 1023 Bonvoust, F., 327 Charney, D., 954 Amato, G., 1407 Bordessoule, D., 196 Charoenratanakul, S., 741 Amatya, V.J., 970, 1203 Bordi, C., 1094 Chau, Y., 1403 Ambinder, R.F., 963 Bornstein-Quevedo, L., 1252 Chen, B.-F., 479 Amin, M.B., 74 Bostwick, D.G., 74 Chen, C.-L., 1240 Amo-Takyi, B.K., 559 Botchan, A., 36 Chen, H., 479 Amunni, G., 360 Boucher, D., 230 Cheng, S.-H., 1016 Anderson, R.E., 459 Boudousquie, A.C., 178 Chertcoff, A., 500 Aozasa, K., 1403 Boulland, M.-L., 196 Chetty, R., 89 Appelman, H.D., 1143 Bouyounes, B., 18 Cheunkongkaew, W., 741 Arai, S., 1050 Bova, G.S., 417 Chew, K., 292 Argani, P., 506 Bovicelli, A., 4 Chi, J.G., 623 Argtielles, R., 569 Bovicelli, L., 4 Chirala, M., 940 Ariza, A., 227 Bozzini, J.P., 500 Cho, E.Y., 954 Arkadopoulos, N., 1371 Braasch, J.W., 18 Cho, Y.J., 297 Armengol, M.-P., 227 Bragg, S.L., 750 Choi, H., 1300 Aronson, A,J., 205 Bramante-Schreiber, L., 803 Choi, H.-Y., 643 Arpesella, G., 1078 Brambilla, C., 918 Choi, Y.-J., 1125 Asuwa, N., 242 Atherton, J.C., 264 Brambilla, E., 918 Chong, S.M., 42 Brat, D.J., 638 Chott, A., 545 Au, W.Y., 126 Aubert, J.-P., 274 Brechot, C., 904 Chung, W.-K., 643 Ayata, G., 814 Brichon, P.-Y., 918 Chung, Y.-F., 1016 Azzoni, C., 1094 Bringuier, A.-F., 1190 Ciepy, K., 428 Bronner, M.P., 368 Cihak, R.W., 139 Cina, S.]., 630 Brooks, ].D., 441 Brooks, J.S.J., 139 Cinti, C., 4 BA, N., 327 Brousset, P., 95, 288 Cleton-Jansen, A.-M., 1416 Baba, M., 1064 Bruch, L.A., 156, 1102 Cohen, B.H., 649 Bae, J.H., 250 Cohen, M.B., 791 Buchler, M.W., 1174 Bajani, M.D., 750 Cohen, R.J., 242, 441 Buckner, S.-B., 1323 Bakker, A., 1039 Buhring, H.-J., 545 Coindre, J.-M., 105 Baldetorp, B., 311 Collin, F., 105 Buisine, M.-P., 274 Baloglu, H., 615 Comin, C.E., 529 Burke, L., 129 Banner, B., 1087 Bussaglia, E., 569 Cooke, H.J., 36 Bansard, J.-Y., 1209 Copin, M.-C., 274 Bussolati, G., 468 Baranowska-Daca, E., 1125 Cordon-Cardo, C., 537 Butler, D.R., 1309, 1318, 1323 Barranco, C., 1197 Corleto, V.D., 1094 Barrios, R., 863, 1125 Costa, S., 4 Batts, K.P., 357 Coulange, C., 282 Baumforth, K.R.N., 963 Coulomb-L’Hermine, A., 320 Becchina, G., 1407 CABALLERO, A., 500 Cover, T.L., 264 Beckwith, J.B., 506 Cagle, P.T., 863, 1059 Crafa, P., 1094 Bedossa, P., 327 Cai, D.X., 156 Crevon, M.-C., 320 1423 HUMAN PATHOLOGY Volume 32, No. 12 (December 2001) Crum, C.P., 479 FANBURG-SMITH, J.C., 976 Ghazizadeh, M., 1050 Cunnane, M.F., 1140 Fayt, I., 135 Gianani, R., 119 Cviko, A., 479 Fecko, A., 690 Gilchrist, A., 1269 Fekete, E., 50 Cill, J., 447 Feldmann, G., 1190 Gilliard, G., 149 Fend, F., 1264 Gilson, T., 216 Fernandez-Figueras, M.-T., 227 Giordano, A., 4, 360 D’Acatl, V.D., 734 d’Amati, G., 1078 Ferno, M., 311 Giordano, F., 1022 Ferrandina, G., 4 Giorgi, R., 282 Daa, T., 352 Ferrans, V.J., 188 Glaser, D., 842 Daimaru, Y., 1203 Fetsch, J.F., 704, 715, 873 Glickman, J.N., 1087, Daniel, L., 282 Fiche, M., 129 Gloeckner, K., 1136 Darai, E., 1190 Figarella-Branger, D., 282 Gobbi, H., 785 Dargent, J.-L., 135 Dargére, D., 3 27 FigurskiJ,. , 690 Goerz, E., 241 Filipovich, A.H., 963 Goldblum, J.R., 368, 379 Date, Y., 237 Finkelstein, S.D., 1039 Gomibuchi, M., 1050 Davis, J.R., 1283 Finn, W.G., 66, 1277 Gordon, F.D., 814 Davoli, C., 1094 Fiore, F., 1078 Gorstein, F., 1, 567, 1027, 1417 Day, M.L., 690 Fischer, G., 242 Gosselin, B., 274 Dayal, Y., 1184 Fisher, S.1., 1327 Gould, V.E., 1356 de Bolos, C., 1197 Flavell, J.R., 963 Graham, A.R., 1283 de Miguel, M., 1232 Fleischer, A., 559 Graham, D.Y., 698 de Sousa, C.P., 487 Fletcher, C.D.M., 1382 Green, L.K., 863 Dehner, L.P., 156, 1102, 1109 Florendo, C., 292 Greenson, J.K., 368, 379 Delahunt, B., 590 Flores, K.G., 926 Greil, R., 1264 Delle Fave, G., 1094 Fontaine, H., 904 Grenko, R.T., 889 Delsol, G., 95, 288 Ford, J.C., 434 Grignon, D.J., 513 Demetriou, A.A., 1371 Fortunato, M., 656 Grillo, P., 1078 Demetris, A., 1334 Foster, C.S., 567, 1154, 1417 Grizzle, W.E., 856 Demopoulos, R.I., 808, 984 Frahm, S.-O., 605, 1376 Grumet, M., 396 DeschatretteJ,. , 327 Friedlander, D., 396 GuarnerJ,. , 31, 750 Descour, M.R., 1283 Friess, H., 1174 Guillou, L., 105 Dettori, G., 698 From, L., 50 Gulley, M., 963 Devilard, E., 461 Frost, A.R., 856 Gunther, K., 559 DeVries, S., 222, 292 Frost, M., 119 Guo, L., 1071 Dhodapkar, K.M., 396 Fujii, T., 410 Guo, X.-D., 233 di Gioia, C.R.T., 1078 Fujikawa, K., 1363 Di Pasquale, M., 24 Fujimoto, S., 163 Diaz-Cano, S.J., 1232, 1415 Fujiwara, M., 1050 Diciolla, F., 1003 Fukase, M., 796 Haas, M., 205 DieboldJ,. , 129 Fukuhara, T., 970 Haber, M.M., 368, 379 Dini, S., 529 Fukushima, N., 834 Haioun, C., 196 Dirnhofer, S., 1264 Fuller, C.E., 1102 HHaallep,e riLn.P,. , D.9,2 63 1 Domer, P., 205 Funamoto, Y., 945 Donnellan, R., 89 Fung, J.J., 1334 Hamada, T., 410 Donoghue, M., 205 Fung, K.-M., 1277 Hamazaki, S., 1272 Dore, M.P., 698 Furman, J., 1109 Han, S.Y., 250 Dorfman, D.M., 1382 Furuya, M., 163 Harada, K., 302 Drews, R., 1269 Harasawa, S., 237 Druet-Cabanac, M., 196 Hardisson, D., 763 Dudas, M., 537 Dugan, J.M., 18 GALANAUD, P., 320 Hardt, N.S., 884 Galateau, F., 320 Harmon, W,]., 630 Dundar, E., 889 Galateau-Sallé, F., 129 Hart, J., 368, 379 Dunn, B.E., 1283, 1300 Galera, H., 1232 Hasebe, T., 401 Duray, P.H., 233 Gallagher, G., 105 Hasegawa, T., 257, 726 Gallo, P., 1078 Hashiguchi, Y., 988 Gamboa, J.D.M., 149 Hashimoto, H., 1116 Gamboa-Dominguez, A., 1252 Hassner, A., 803 kI BLE, J.N., 513, 590 Gannon, F.H., 842 Hauser, R., 36 Egensperger, R., 1136 Garb, J., 1344 Hayashi, N., 757 Eisenthal, A., 803 Garcia, A., 569 Hayashi, Y., 901, 1071 El-Bahrawy, M.A., 1216 Garrido, M., 1197 Heidebrecht, H.-J., 311 Elliott, D.J., 36 Gascon, J., 1023 Heidorn, K., 605 Ely, S.A., 339 Gasparini, R., 1344 Heimburger, D.C., 856 Emilie, D., 320 Gaulard, P., 196 Heitmuller, R.F., 447 Endrizzi, J].M., 630 Gazdar, A.F., 169, 753 Hejmanowski, A.Q., 521 Eng, ¢ Gebhard, S., 105 Helfenstein, A., 605 Enzan, H., 107] Geller, S.A., 665 Henrique, R., 487 Epistolato, M.C., 1003 Gerald, W., 537 Henry, M.D., 791 Epstein, J.I., 74, 81, 389, 417, 494, 506, Gerhard, D.S., 475 Herrera-Goepfert, R., 31 630, 997, 1141, 1209, 1278, 1417 Gerridzen, R., 434 Herring, R.F., 1309 Esposito, I., 1174 Gerschenson, L.E., 1029 Herrington, C.S., 1351 Esumi, H., 1043 Gersell, D.J., 475 Hill, D.A., 156 Etzel, [.E.; 222, 292 Geske, FJ., 1029 Hirabayashi, J., 302 1424 AUTHOR INDEX Hirai, K., 1064 Johnson, M.H., 74, 81, 1278, 1417 Klemen, H., 333 Hiraoka, K., 410 Jonat, W., 605 Knapik, J., 884 Hirohashi, S., 257, 834 Jones, E.C., 74, 101, 513 Knudsen, K.A., 149 Hiroi, M., 1071 Jones, J., 615 Ko, Y.-H., 954 Hiroi, S., 188 Jones, M.K., 178 Kobayashi, K., 1064 Hisaki, R., 237 Joo, M., 250 Kobori, K., 887 Hisaoka, M., 1116 Jordan, J.-H., 545 Kocher, O., 1269 Ho, L.T., 205 Josephson, M., 205 Kodama, H., 887 Hoang, M.P., 753 Juan, M., 227 Komiya, S., 410 Honda, K., 352 Judkins, A.R., 240 Kondo, K., 1064 Honda, Y., 1225 Jundt, G., 105 Kono, N., 302 Hongyo, T., 1403 Jurecka, W., 545 Koss, L.G., 615 Horie, T., 237 Kosuge, T., 834 Horny, H.-P., 545 Koukoulis, G.K., 823, 899, 1356 Hosaka, M., 1064 Kapin, M.E., 1269 Kovacs, G., 101 Hoshii, Y., 237 Kahn, H.]J., 50 Kronz, J.D., 389 Hoshino, Y., 757 Kallakury, B.V.S., 849 Krupinski, E.A., 1283 Hruban, R.H., 638 Krupp, G., 605 Kambham, N., 734 Hu, H., 42 Kamiya, K., 348 Kulthanan, K., 741 Huang, A.-C., 1240 Kanai, Y., 834 Kumaki, F., 188 HHuuhe,t tJn.e,r ,9 54P .C., 475 Kanavaros, P., 196 Kumar, K., 1147 Kanda, H., 1116 Kumon, Y., 910 HHuuim,p hAr.-eMy.,, 7P7.1A ., 74, 935, 1102, 1109 Kaneko, S., 1064 Kuno, K., 132 Kang, Y.K., 250 Kuo, L.H., 500 Hunt, J.A., 894 Hunt, J.L., 1020 Kanmatsuse, K., 237 Kurisu, K., 970 Kant, J.A., 677 Kuroda, N., 1071 Husain, A.N., 506 Kapadia, I., 1318 Kusano, M., 348 Huston, D.P., 346 Kutok, J.L., 1382 Kaplan, F.S., 842 Hutchins, G.M., 55; Kappeler, A., 1174 Kuzushima, K., 757 Hwang, E.S., 222 Karademir, S., 823 Kwong, Y.L., 126 Karahuseyinoglu, E., Karnovsky, M.J., 459 IBANEZ, C., 500 Kasai, K., 302 LABONTE, S., 230 Icard, P., 129 Kashani, A.H., 553 Lagarda, H., 569 Iglseder, B., 1136 Kashima, K., 352 Lar, R., E32 Hjiri, R., 880, 1012 Kasuga, M., 910 Lakari, E., 1257 Ikawa, H., 910 Kato, K., 880, 1012 Lalinga, A.V., 1003 Ikeda, M., 880 Kato, N., 796 Lam, €.C.K., 126 Imamura, T., 1116 Kato, S., 410 Lamant, L., 95 Inai, K., 970, 1203 Kato, Y., 1012, 1064 Lamps, L.W., 368, 379 Inayama, Y., 1064 Katoh, R., 10 ane, C.G., 74, 81, 1278, 1417 Indurkhya, A., 1147 Kattan, M.W., 828 ane, R.B., 74, 81, 1278, 1417 Inoue, K., 1071 Katzenstein, A.-L.A., aantuéjoul, S., 918 Inoue, T., 988 Kawai, T., 188 arue, H., 230 Irie, H., 887 Kawakami, S., 1064 askin, W.B., 704, 715, 745 Irie, K., 410 Kawanami, O., 1050 aucirica, R., 113 Ishida, T., 1116 Kawaoi, A., 10 aurent, P., 320 Ishihara, A., 1225 Kawasaki, H., 1043 aauwers, G.Y., 368, 379 Ishii, T., 242 Kayser, K., 1283 vaverriére, M.-H., 918 Ishiko, O., 988 Kern, S.E., 638 aawson, A., 1334 Ishikura, H., 163 Khettry, U., 814 ppppfepeeeeeeettdtteddd at zee nby, A.J., 368, 379 Itakura, E., 1225 Kim, C,J., 623 Le Doussal, V., 105 Ito, Y., 880 Kim, C.W., 954 Leal, C., 487, 537 Itoh, H., 910 Kim, G.-M., 643 Lechevallier, E., 282 Ivanoviene, L., 1003 Kim, H.-I., 643 Lechner, K., 545 Iwamoto, Y., 1225, 1245 Kim, H.S., 250, 297 Lecksell, K., 997 Iwasaki, Y., 237 Kim, J.-H., 643 Lee, H.K., 250 Kim, M.-K., 643 Lee, H.S., 250 Kim, M.H., 623 Lee, J.-S., 643 Kim, S.H., 250 Lee, J.H., 250 JANG, J.J., 250 Kim, S.U., 643 Lée, |-Y.; 250 Janssen, N.M., 346 Kim, S.Y., 250 Lee, M.-C., 643 Jarboe, E., 119 Kim, W.H., 297 Lee, S.H., 250 Jarosz, B., 1304 Kimura, H., 757 Lee, S.S., 954 Jarry, A., 461 Kinnula, V.L., 1257 Leenutaphong, V., 741 Jeffery, R., 1216 Kinukawa, N., 237 Lehner, R., 119 Jenkins, R.L., 814 Kisagawa, H., 1012 Les, [-¥., 233 Jensen, D., 823 Kishida, T., 1064 Leone, O., 1078 Jensen, R.A., 785 Kitahara, Y., 237 Lerochais, ].P., 129 Jerome, K.R., 342 Klapper, W., 605 Leroy, K., 196 Jin, E., 1050 Kleeff, J., 1174 Lesauskaite, V., 1003 Jin, Y., 887 Kleiman, S.E., 36 Lespagnard, L., 135 Johanning, G.L., 856 Klein, E.A., 1392 Leteurtre, E., 274 Johl, J., 963 Kleinschmidt, I., 89 Levin, H.S., 1392 1425 HUMAN PATHOLOGY Volume 32, No. 12 (December 2001) Levy, B.K., 156 McNeal, J.E., 242, 441, 1142 Nakazato, M., 237 Lewin, D.N., 368, 379 McWilliams, G., 233 Nalesnik, M., 1334 Lewin, K.J., 247 Meehan, S.M., 205 Nalpas, B., 904 Lewis, J.E., 596 Meggetto, F., 95, 288 Nam, S.-C., 643 Lewis, W.D., 814 Menéndez, C., 1023 Nanba, I., 1012 Merino, M.]J., 233 Nandedkar, M.A., 1327 Li Meschis, L., 1407 Naruse, K., 107] 11, [-Q., $ Michels, J.-J., 105 Nash, J.R.G., 1154 La X. Middleton, L.P., 233 Nassar, G., 1125 Li : 3, 475, 940 Midulla, R., 1407 Naughton, C.K., 935 Lij ang, C., 1283 Miettinen, M., 704, 873, 976 Nebuloni, M., 1022 Libertino, J.A., 18 Miki, H., 945 Nelson, P.T., 663 Lifschitz-Mercer, B., 803 Milbrandt, J., 935 Nemori, R., 163 Lindner, B., 1136 Milchgrub, S., 169 Neri, E., 1003 Linehan, W.M., 233 Milord, R.A., 997 Newcomb, E.W., 808 izo0u,.1S., 1392 Minervini, M.I., 1334 Ng, I.0., 778 Liu, N., 57 Minimo, C., 4 Ng, M.H.L., 1016 LiVolsi, V.A., 351, 1140, 1413 Misonznik, F., 803 Nguyen, H., 1147 Ljung, B.M., 292 Misugi, K., 1012 Nguyen, T.U., 346 Lo, K.-W., 1016 Mittal, K., 984 Ninomiva, T., 910 Lobel, B., 1209 Miyagi, E., 10 Nishi, T., 1012 Loh, K.S., 42 Miyazaki, E., 1071 Nishisaka, T., 970 Lomakin, I., 1184 Miyazaki, K., 302 Nishiwaki, Y., 1043 Lopes, C., 487 Mohar, A., 31 Nistal, M., 763 Lopes, P., 487 Mohr, W., 241 Niveleau, A., 856 Lopez-Ferrer, A., Molina, T., 129 Nobukawa, B., 447 Lou, I.-U., 1240 Molinaro, A., 292 Noel, J.-C., 135 Lowe, D., 963 Molnar, P.P., 1021, 1414 Noumoff, J.S., 762 Luszcz, J., 1344 Monga, G., 656 Novelli, L., 529 Monteiro, P., 487 Nuovo, G,]J., 216 Montgomery, E., 368, 379 Morash, C., 434 Ma, E.S.K., 126 Morgan, J., 750 Machin, P., 569 O'Leary, T.J., 578, 1309, 1318, 1323 Madelenat, P., 1190 Morishima, T., 7! O’Sullivan, M.J., 475, 1109 Magelli, C., 1078 Morrison, C.D., 2 Oberascher, G., 1136 Mai, K.T., 434 Morrow, J.S., 14: Obrist, P., 1264 Mosberger, I., 545 Maitra, A., 169, 753 Ochiai, A., 401 Majno, G., 898 Mosca, W., 149 Oda, Y., 1225, 1245 Moser, P., 1264 Makuuchi, M., 771 Odze, R.D., 1087, 1157 Mosnier, J.-F., 1166 Man, C., 126 Oelschlager, D., 856 Mancuso, S., 4 Mosnier-Damet, M., 1166 Oghalai, ].S., 346 Motoyama, T., 796 Manegold, E., 559 Ogita, S., 988 Mangold, K.A., 74, 81, 1278, 1417 Mou, L., 57 Ogura, T., 1043 Moulinoux, J.-P., 1209 Mann, S., 113 Oh, R.R., 250 Mourey, L., 288 Manunta, A., 1209 Ohaki, Y., 1050 Manzotti, M., 1410 Mucci, N.R., 417, 690 Ohbayashi, C., 910 Mukai, K., 834 Marconi, S., 1344 Ohmori, M., 945 Mullick, F.G., 1309 Marcus, A., 57 Munoz, J., 569 Ohmori, S., 1363 Maresi, E., 1407 Ohori, M., 828 Mura, D., 698 Mariano, M., 500 Ohori, N.P., 1039 Murray, P.G., 963 Marino, B., 1078 Okada, K., 726 Marino, LR., 1334 Murry, C.E., 342 Okada, S., 1272 Murry, T.C., 240 Markowitz, G.S., 734 Okamoto, S., 1116 Marquette, C.H., 274 Okazaki, E., 796 Martin, J.L., 149 Ollayos, C.W., 1318, 1323 Maru, N., 828 NAEEM, R., 1344 Olsen, K.D., 596 Masciullo, V., 4, 360 Nagahara, N., 1012 Olson, S.J., 487, 785 Massarelli, G., 698 Nagai, J., 1012 Olsson, H., 31] Massi, D., 360 Nagai, K., 1043 Onida, A., 698 Massi, G., 360 Nagano, H., 910 Ono, L., 796 Massip, P., 288 Nagasaka, T., 132, 757 Ono, M., 401 Matias-Guiu, X., 569, 1416 Nagashima, M., 1050 Onuma, K., 880 Matsumoto, K., 796 Nagashima, Y., 880, 1064, 1272 Ordi, J., 1023 Matsuno, Y., 257 Nagata, K., 410 Orjuela, M., 537 Maymon, B.B.-S., 36 Nagura, S., 10 Orlando, E., 1407 Mazzarol, G., 1410 Nakaji, M., 910 Orlicky, D., 119 Mazzucco, G., 656 Nakano, T., 1203, 1363 Orlow, I., 537 McCarthy, D.M., 638 Nakanuma, Y., 302 Ormsby, A.H., 1392 McCredie, M.R.E., 590 Nakasato, Y., 887 Oshiro, Y., 1225, 1245 McCue, P.A., 1027 Nakashima, H., 1272 Ostrowski, M.L., 863 McDicken, I.W., 1351 Nakashima, N., 132 Otis, C.N., 1344 McGregor, D.K., 346 Nakashima, T., 132 Ottoveggio, G., 1407 McKeon, F.D., 479, 1157 Nakayama, I., 352 Ozden, O., 745 McMahon, J.T., 649 Nakayori, F., 1203 Ozeki, Y., 188 1426 AUTHOR INDEX PAAKKO, P., 1257 RADER, J.S., 475 Sepulveda, A.R., 698 Pacchioni, D., 468 Ragni, M.V., 963 Sesterhenn, I.A., 74 Page, D.L., 487, 785 Ramee, M.-P., 1209 Sethi, S., 660 Paglierani, M., 360, 529 Ramesh, H., 1174 Shah, R.N., 745 Palazzo, J.P., 24, 769 Randhawa, P., 1334, 1388 Shahsafaei, A., 1157 Pallotti, F., 1022 Rao, S., 745 Shaikh, A.A., 389 Palmerini, F., 461 Rathor, S., 884 Sharma, A., 1059 Pan, C.C., 494 Realdi, G., 698 Shaw, H., 428 Pan, X., 1050 Recla, D.L., 1300 Sheehan, C.E., 849 Papadimitriou, J.C., 894 Ree, H.]., 954 Sheen, T.-S., 1240 Papierz, W., 1304 Reichenbach, D.D. Shen, J., 823, 1356 Papotti, M., 918 Remotti, F., 873 Shi, ¥.-Z., 771 Papp, A.C., 521 Renner, H., 333 Paradis, V., 327 Rennke, H.G., 660 Shibata, M., 163 Park, J.K., 250 Reusche, E., 1136 Shibuya, M., 10 Park, S.-S., 623 Reuter, V.E., 74 Shieh, W.-J., 750 Park, S.H., 297 Ribera, M., 227 Shiga, J., 887 Park, W.S., 250 Richter, L., 1283 Shimada, K., 834 Parmigiani, G., 417 Ridaura, C., 537 Shimajiri, S., 1116 ParsonnetJ,. , 31 Rieger-Christ, K.M., 18 Shimizu, H., 1050 Parwani, A.V., 506 Rioux-LeClercq, N., 1209 Shimizu, Y., 348 Parwaresch, R., 311, 605, 1376 Ripley, D., 884 Shimoda, T., 257 Pasquali, C., 1094 Ro, J.Y., 863 Shimonishi, T., 302 Passantino, R., 1407 Robert, M.E., 368, 379 Shin, M.S., 250 Patard, J.-J., 1209 Rosai, J., 352 Shinomiya, N., 188 Paz, G., 36 Rosenberg, E., 808 Shiraki, K., 1363 Peek, R.M. Jr., 264 Rosenthal, D.L., 1318 Shivapurkar, N., 169 Pellegrinelli, A., 1022 Ross, C.W., 66 Shore, E.M., 842 Perez-Perez, G.I., 264 Ross, J.S., 849 Shrikhande, S., 1174 Perlman, E.J., 1109 Rosser, R.J., 1416 Shroyer, K.R., 119 Rothstein, J.L., 24 Perry, A., 156, 1102 Shuin, T., 1071 Rubin, M.A., 417, 690 Pesti, T., 101 Shyr, Y., 264, 368 Rudolph, P., 311, 605, 1376 Peterson, L., 745 Sichez, H., 282 Petit, B., 196 Sieben, N.L., 1416 Petrovic, L.M., 1371 Silva, M.d.A., 487 Pettay, J.D., 1392 Silverman, M.L., 18 Petzmann, S., 333, 1059 SasiT, H., 302 Simpson, J.F., 785 Pfeifer, J.D., 1102, 1109 Sadhu, A., 205 Sinard, J.H., 143 Piard, F., 320 Saito, F., 237 Singleton, T.P., 66 Pienta, K.J., 690 Saitoh, N., 401 Skacel, M., 1392 Pierson, C.R., 513 Sakai, N., 1064 Sobonya, R.E., 669 Pietarinen-Runtti, P., 1257 Sakai, T., 1363 Soini, Y., 1257 Pilz, P., 1136 Sakamaki, T., 25 Pinkus, G.S., 1382 Sakamoto, A., Soler, A.P., 149 Piyathilake, C.J., 856 Sakamoto, M., 83 Somerhausen, N.d.S.A., 105 PPiozlz,i , S.S,. ,9 0140 94 SSaaklra,z arW,. ,A .,7 4 537 SSoorriecnh,s enJ,., 8P0.8H. B., 513 Samel, A., 1269 Southern, S.A., 1351 Polizzotti, G., 1022 Polyvkin, N., 803 Sanchez, L., 31 Spark, R.P., 1142 Sanders, M.E., 1276 Sperr, W.R., 545 Pomfret, E., 814 Sangruchi, T., 741 Speyer, J.L., 808 Pommier, R.F., 178 PomposellJi.,J. , 814 Santini, D., 4 Spina, D., 1003 Sarkar, F.H., 513 Srigley, J.R., 513 Ponce-Castaneda, M.V., 537 Poncelet, C., 1190 Sasaki, S., 401 Srivastava, A., 1184 Pons, C., 569 Sassi, C., 1003 Stadlmann, S., 1264 Popper, H.H., 333, 863, 1059 Savici, D., 1398 Stewart, J.H., 590 Porchet, N., 274 Scambia, G., 4, 360 Stoolman, L.M., 66 Porte, H., 274 Scanlan, R.M., 178 Sturm, N., 918 Poulet, B., 904 Scardino, P.T., 828 Sugimoto, K., 1363 Poulsom, R., 1216 Schmidt, W.A., 178 Sugitoh, M., 401 Powell, S., 863 Schnell, C.S., 963 Sugiyama, K., 970 Prasopchoke, P., 741 Schnitzer, B., 66 Suh, J.-J., 643 Schober, M.S., 513 Prat, J., 569, 1416 Schoenberg, M.P., 630 Suki, W.N., 1125 Prayson, R.A., 649 ScholesJ,. , 396 Sukosd, F., 101 Prior, T.W., 521 Schreiber, L., 36 Sukpanichnant, S., 741 Pruneri, G., 1410 Summerhayes, I.C., 18 Schréder, W., 559 Puig, L., 227 Schubert, C., 1376 Sun, D., 479 Pylkas, P., 1257 Scoazec, J.-Y., 1190 Suno, A., 656 Scott, K.M., 1283 Susini, T., 360 Seay, T.M., 630 Suster, S., 352 Sebo, T.J., 596 Swalsky, P.A., 1039 Qin, L., 778 Sehdev, A.E.S., 494 Swinnen, L.J., 963 Quade, B.J., 479 Seo, Y., 910 Szymus, J., 1283, 1304 1427 HUMAN PATHOLOGY Volume 32, No. 12 (December 2001) Tappel, G.L., 360 Tuneyama, K., 302 XERRI, L., 461 Taguchi, K., 1272 Turlin, B., 1209 Xiong, Y., 149 Takahashi, I., 887 Au, JL. 757 Takase, K., 1363 Takayama, T., 771 Takemura, T., 1050 ULLMANN, R., 333, 1059 YACHNIS, A.T., 884 Takeshima, Y., 970, 1203 Yagi, H., 237 Takimoto, M., 348 Yagi, Y., 1334 Talbot, I., 1216 Yamamoto, K., 988 T ‘alerman, A., 884 VALENT, P., 545 Yanagawa, Y., 887 I‘ amiya, S., 1225, 1245 Vatanavicharn, S., 741 Yang, A., 479, 1157 I an, 1.K-S.--42 Velasquez, J.N., 500 Yang, W.I., 954 |a n. S.Y.- 42 Verhest, A., 135 Yang, Y., 57 I anaka, N., 757 Vetto, J.T., 178 Yang, Y.-C., 479 I‘ anaka, Y., 880, 1012 Viale, G., 1410 Yano, H., 410 T ‘ang, K.F., 42 Vince, D.R., 105 Yano, Y., 910 I‘ anganelli, P., 1003 Virtanen, I., 1356 Yao, M., 1064, 1272 I‘ anji, K., 734 Volante, M., 468 Yavetz, H., 36 I‘ anji, N., 734 Yee, H., 808 I‘ appero, J.W., Yeldandi, A., 745 Tavassoli, F.A., 71! Yeo, C.J., 638 Fellado, M.V., 1323 WacayaMa, H., 1363 Yogev, L., 36 Perrier, P., 105 Wagner, B.M., 1278 Yokose, T., 1043 Terzano, P., 4 Walchshofer, S., 545 Yokoyama, R., 257, 726 Tétu, B., 230 Waldman, F.M., 222, 299 Yokoyama, S., 352 Tham, K.T., 264 Walker, F., 1190 Yoo, N.J., 250 Wallis, T., 513 Thistlethwaite, J.R., 205 Yoon, B.H., 623 Thompson, L.D., 842, 1318 Walsh, M.M., 583 Yoon, S., 910 Thor, A., 222 Walsh, N.M.G., 680 Yoshida, M., 1064, 1272 Thurmond, A., 178 Wan, T., 126 Yoshikawa, T., 887 Wang, T.-Y., 479 Tietze, L., 559 Yoshiki, T., 163 Wang, Y., 479 Tizzani, A., 468 Younes, A., 113, 940 Washington, K., 368, 379 Toi, M., 1071 Younes, M., 113, 940 Toledano, A.Y., 368 Watanabe, T., 237 - Younes, P.S., 113 Toomey, S.M., 963 Weinstein, R.S., 1, 669, 1283, 1304 Young, L.S., 963 Torbenson, M., 1388 Weiss, H., 856 Yousem, S.A., 428, 1039 Torikata, C., 188 Werner, A., 339 Youssef, N., 327 Tosi, D., 1022 West, K.P., 1154 Yutani, C., 237 Wheeler, T.M., 74, 417, 828 Toyoda, Y., 880, 1012 Wilentz, R.E., 638 Trassard, M., 105 Trinka, E., 1136 Wilkinson, E.J., 884 ZAHURAK, M.L., 379 Trinkaus, K.M., 475 WWiilllliaimasm, sJ,.B .,H .8,2 3 1309, 1318, 1323, 1327 ZZaakmip,a rSe.lRl.i, , 75A0., 4 TTrrounocnogs,o , L.DP..,, 7141 25 Witte, D., 940 Zattara-Cannoni, H., 282 Tsang, K.-S., 1016 WWoollff,e , G.H,. J.1,3 041 232 ZZeelnemnyiou,c h-JM.a,c qu4o1t0t e, A., 808 Tsao, M.-S., 57 Wolff, K., 545 Zimmermann, A., 1174 Tsiftsakis, E.K., 1392 Wong, N., 1016 Zippe, C.D., 1392 Tsuda, H., 988 Woo, Y.-J., 643 Zitella, A., 468 Tsuneyoshi, M., 1225, 1245 Wu, F., 945 Zoppi, L.B., 149 Tsunoda, A., 348 Wu, M.L., 247 Zorini, E.O., 656 Tsunoda, Y., 348 Wu, T., 1334 Zou, W., 320 Tubbs, R.R., 1392 Wu, T.-T., 447, Zylberberg, H., 904 Index of Subjects for Volume 32 The following is a list of page numbers according to issue pulmonary for Volume 32 (2001) of HUMAN PATHOLOGY: and synchronous extranodal marginal zone/low-grade B-cell lymphoma, 129-132 HRES RAR YPEa ce retest, swcsyastiesSevcastastackeeeeteh aeteasanstialdiaacese s ; markers to differentiate pleural epithelial mesothelioma from, 529-536 February . 143-246 urinary bladder, primary and secondary prostatic, 434-440 March 247-356 Adenoid cystic carcinoma April . 357-458 dedifferentiation of, 1403-1407 May ... 459-566 Adenoma June 567-668 adrenal cortical, proliferative, microvessel network in, 1232-1239 July 669-768 colorectal, deletions of chromosome 4 in pathogenesis of, 169- August 769-898 177 September 899-1026 intrathyroidal water-clear cell parathyroid, 889-892 October 1027-1146 metanephric, chromosome 2p13 in, 101-104 Adenoma-carcinoma sequence, in colon cancer 1147-1282 survivin expression in normal, hyperplastic, and neoplastic co- 1283-1446 lonic mucosa, 119-125 Adenomatous polyposis coli (APC) gene in nasopharyngeal angiofibroma (Correspondence), 455 Adhesion molecules ACOUSTIC NEUROMA expression in CD5—/CD10— chronic B-cell leukemias, 66-73 subacute fatal aluminum encephalopathy after surgery for, 1136- neural cell, overexpression of in Chagas’ myocarditis, 149-155 1140 Adhesion proteins Acquired (digital) fibrokeratoma co-downregulation of, in prostatic adenocarcinoma, 849-855 vs. supreficial acral fibromyxoma, 704-714 Adrenal cortex Acquired immunodeficiency syndrome (AIDS) proliferative lesions of, microvessel network in, 1232-1239 apoptosis and, 1034 Adrenal gland human herpesvirus-8 in bone marrow biopsies of HIV-positive Ewing’s sarcoma family of tumor arising in, 1012-1016 patients, 288-29] Age isosporosis and unizoite tissue cysts in, 500-505 and Helicobacter genotypes in peptic ulcer disease, 264-273 Acral fibromyxoma AgNOR, see Silver-staining nucleolar organizer region superficial, 704-714 Allelic losses Acral myxoinflammatory fibroblastic sarcoma, 704-714 in short- vs. long-segment Barrett esophagus, 447-454 Acral pseudolymphomatous angiokeratoma Allelotyping cutaneous lymphocyte antigen expression in, 227-229 loss of heterozygosity at 11q23.3 in squamous cell carcinoma of Acute promyelocytic leukemia cervix, 475-478 therapy-related myelodysplastic syndrome after, 126-129 Allograft, renal Acute respiratory distress syndrome (ARDS) arcuate and interlobular phlebitis in, 1388-1391 diffuse alveolar damage and, 1398-1402 plasmacytic infiltrates in percutaneous biopsies of, 205-215 Acute tubular necrosis polyomavirus BKV strain in recipient of, 656-659 adefovir nephrotoxicity leading to, 734-740 post-transplant lymphoma in hypopharynx of recipient, 1264- Adefovir 1268 nephrotoxicity of, role of mitochondrial DNA depletion, 734-740 Aluminum Adenocarcinoma subacute fatal encephalopathy after reconstructive neurosurgery, Barrett esophagus 1136-1140 dysplasia as predictive marker for, 379-388 Alveolar capillary endothelium early, in short- vs. long-segment, 447-454 remodeling of, with aerogenous spread of primary lung adeno- bronchioloalveolar, absence of Jaagsiekte sheep retrovirus in, carcinoma, 1050-1058 1039-1042 Alzheimer’s disease colonic, survivin expression in, 119-125 apoptosis and, 1034 colorectal American Board of Pathology (ABP) deletions of chromosome 4 in pathogenesis of, 169-177 accredited programs and persons certified by, 671-673 estrogen receptor B in, 940-944 Ammon horn sclerosis endometrial, Rb2/p130 expression in, 360-367 in temporal lobe epilepsy, 643-648 endometrioid, high telomerase activity in, 605-614 Ampulla of Vater lung, primary carcinoid tumors of, 1252-1256 aerogenous spread of, and alveolar capillary remodeling, 1050- Amyloidosis 1058 late-onset cardiac, with new transthyretin variant, 237-239 pattern of mucin gene expression in, 274-281 localized, and extramedullary plasmacytoma of larynx in child, pancreatic 132-134 infiltrating, DPC4 in, 638-642 subcutaneous nodular, 346-348 Nr-CAM expression in, 396-400 Anaplastic lymphoma kinase (ALK) immunostaining prostatic and 2p23 in pulmonary inflammatory pseudotumors, 428-433 cell adhesion proteins in, 849-855 Anaplastic meningioma comparison of sampling methods for nonpalpable, 494-499 immunohistochemical study of, 970-975 cytologic criteria in histologic diagnosis of Gleason grade 1, Anatomic pathology 441-446, 1141-1142 (Correspondence) informatics and (Editorial), 143-148 E-cadherin in, tissue microarray technology in, 690-697 teaching of, in England and Wales (Editorial Comment), 11541 156 1429 HUMAN PATHOLOGY Volume 32, No. 12 (December 2001) Anencephaly Atomic absorption spectrometry meningeal-cutaneous relationships in, 553-558 aluminum encephalopathy after reconstructive otoneurosurgery, Aneurysm 1136-1140 dialtative pathology of thoracic aorta, 1003-1011 Atrophy ruptured coronary, sudden infant death caused by, 1407-1409 gastric, in Helicobacter pylor-infected patients, 31-35 Angiocentric lymphoproliferative lesion Atypical ductal hyperplasia orbital, with immature natural killer cell immunophenotype, 339- perineural invasion of breast by, 785-790 Atypical endometrial hyperplasia 342 Angiocentric T-cell lymphoma comparative genomic hybridization of endometrioid carcinoma and, 615-622 of pancreas, presenting as diabetes mellitus, 741-745 Rb2/p130 gene expression in, 360-367 Angiofibroma Atypical fibroxanthoma nasopharyngeal, lack of APC gene alterations in, 455 (Corre- H-, K-, and N-ras mutations in, 1225-1231 spondence) Atypical teratoid/rhabdoid tumors Angiogenesis chromosome 22q dosage in, vs. medulloblastoma/central primi- and CD34 expression in chronic liver disease, 1363-1370 tive neuroectodermal tumors, 156-162 Angiokeratoma, acral pseudolymphomatous Autoimmune disorders cutaneous lymphocyte antigen expression in, 227-229 Graves disease, vascular endothelial growth factor in, 10-17 Angiotensin-converting enzyme gene Autonomic nerve tumor, gastrointestinal polymorphism of, in pulmonary fibrosis, 521-528 protein tau in, 1166-1173 Antigen retrieval Axillary skin biopsy Antigen Retrieval Techniques: Immunohistochemistry and Molecular Mor- ultrastructural examination of, in diagnosis of metabolic diseases, phology (book review], 351 649-655 Antioxidants Azoospermia, nonobstructive hemeoxygenase 1, in healthy lung and interstitial lung disorders, RNA-binding motif (RBM) antibody in testicular biopsies of men 1257-1263 with, 36-41 Antiviral agents adefovir, nephrotoxicity of, 734-740 Aorta B CELLS medial calcification of, 241-242 (Correspondence) in epithelial and perivascular compartments of adult thymus, Aorta, thoracic 926-934 smooth muscle cells of media in dilatative pathology of, 1003- B-cell lymphomas 1011 Bcl-6 and CD10 coexpression in diffuse large, 954-962 Apocrine ductal carcinoma Barrett esophagus in situ, of breast, histologic classification and markers, 487-493 dysplasia as predictive marker for invasive carcinoma, 379-388 Apoptosis high-grade dysplasia and early adenocarcinoma in short- vs. long- biology of, 1029-1038 segment, 447-454 AIDS and, 1034 more steps forward (Editorial), 357-359 Alzheimer’s disease and, 1034 classification of dysplasia in, 357-358 apoptotic regulation, 1032-1034 clinical relevance of grading, 358 cell membrane changes, i031 definition disease and, 1034-1035 reproducibility of grading of dysplasia, 358 heart disease and, 1034 short- versus long-segment, 359 history, 1029-1030 p63 expression in, 1157-1165 mitochondrial changes, 1031 reproducibility of diagnosis of dysplasia in, 368-378 modulating therapies, 1035 Basaloid carcinoma multiple sclerosis and, 1034 of lung, thyroid transcription factor 1 and cytokeratin expression nuclear changes, 1039-1031 in, 918-925 proteolytic changes, 1031-1032 Basement membrane cardiomyocyte apoptotic bodies, thanatosomes and, 894-895 dystroglycan in breast and prostate cancer, 791-795 (Correspondence) Bcl-2 caspase 7 downregulation as marker of colon carcinoma, 461-467 in biology of apoptosis, 1029-1038 cholangiocytic, in chronic ductopenic rejection, 823-827 Bel-6 dilatative pathology of thoracic aorta, 1003-1011 and CD10 in diffuse large B-cell lymphomas, 954-962 Bcl-x, microvessel network in adrenal cortical proliferative lesions, in bone marrow mast cells in systemic mastocytosis, 545 1232-1239 Bile ducts, intrahepatic of Fas in hepatocellular carcinoma, 250-256 cholangiocytic apoptosis in chronic ductopenic rejection, 823- survivin expression in normal, hyperplastic, and neoplastic co- 827 lonic mucosa, 119-125 endogenous galectins in intrahepatic cholangiocarcinoma, 302- Arcuate vein 310 phlebitis in, in renal allografts, 1388-1391 Biliary epithelial dysplasia Armed Forces Institute of Pathology (AFIP) endogenous galectins in intrahepatic cholangiocarinoma, 302- international static image-based telepathology service, 1309-1317 310 telecytology diagnosis of cervical-vaginal smears, 1318-1322 Bioartificial liver telecytology consultation service, characteristics of, 1323-1326 activation of hepatic stellate cells after treatment with, 1371-1375 telehematopathology in clinical consultative practice, 1327-1333 Biologic markers Aromatase of apocrine ductal carcinoma in situ of breast, 487-493 in fine-needle aspirates of breast carcinomas, 348-351 Biopsies Arrhythmogenic right ventricular cardiomyopathy bladder, correlation of cystoscopy with histologic diagnosis, 630- pathologic patterns in, 1078-1086 637 Artifacts bone marrow polymerase chain reaction, in microdissected specimens, 1415- human herpesvirus-8 in HIV-positive patients, 288-291 1416 liver, in chronic hepatitis C (Editorial), 899-903 1430 SUBJECT INDEX prostate Cadherin, E- high-grade prostatic intraepithelial neoplasia with small atypi- co-downregulation of, in prostatic adenocarcinoma, 849-855 cal glands,389-95 in prostate cancer, tissue microarray technology in, 690-697 renal allograft, percutaneous, plasmacytic infiltrates in, 205-215 in sporadic colorectal carcinoma, 1216-1224 renal, in nonlupus nephritides in systemic lupus erythematosus, Cadherins 1125-1135 type I, in urothelial neoplastic progression, 18-23 testicular Calcification RNA-binding motif (RBM) antibody in, in infertile men, 36-41 medial, of the aorta (Correspondence), 241-242 Bladder, urinary Calretinin cadherins type I in urothelial neoplastic progression, 18-23 marker for pleural epithelial mesothelioma, 529-536 cytoscopic impression and histologic diagnosis of biopsy speci- Carcinoembryonic antigen (CEA) mens, 630-637 as negative marker for pleural epithelial mesothelioma, 529-536 flat urothelial carcinoma in situ, diagnosis of, 997-1002 Carcinogenesis primary and secondary prostatic adenocarcinoma of, 434-440 gallbladder, reduced p21““F!/C?! expression in, 771-777 progression from superficial to invasive carcinoma, 468-474 Carcinoids Bone marrow lung, loss of heterozygosity on 11q in, 333-338 mast cells, typing of in systemic mastocytosis, 545-552 of duodenum and ampulla of Vater, 1252-1256 Bone marrow biopsies Carcinoma human herpesvirus-8 in, from HIV-positive patients, 288-291 adenoid cystic, dedifferentiation of, 1403-1407 Bone tumors basaloid and large-cell neuroendocrine, of lung, 918-925 rosette-forming epithelioid osteosarcoma, 726-733 bladder, progression from superficial to invasive, 468-474 Book reviews breast Barlett: Ovarian Carcinoma—Methods and Protocols, 762-763 aromatase in fine-needle aspirates, 348-351 Carpenter & Karpati: Pathology of Skeletal Muscle, 1277 ductal, cyclin E expression in, 89-94 Craighead: Pathology and Pathogenesis of Human Viral Disease, 1413- invasive micropapillary, 583-589 1414 lobular in situ, loss of chromosome 16q in, 292-296 Crawford: The Invisible Enemy: A Natural History of Viruses, 892-894 tubular, genomic alterations in, 222-226 Fajardo et al: Radiation Pathology, 1140-1141 tyrosine kinase activation in, 1344-1350 Fletcher: Diagnostic Histopathology of Tumors, 1021-1022 cervical Fu et al: Head and Neck Pathology with Clinical Correlates, 1140 p53 homologue p63 expression in, 479-486 Killeen: Molecular Pathology Protocols, 1020-1021 squamous cell, loss of heterozygosity at, 11q23.3 in, 476-478 Klatt & Kumar: Robbins Review of Pathology, 240-241 colon McLendon et al: Pathology of Tumors of the Central Nervous System, caspase 7 downregulation as marker of, 461-467 663-664 colorectal Mydlo: Renal Cancer, Methods and Protocols, 1276-1277 cyclin E and cyclin-dependent kinase 2, in, 945-953 Prayson & Cohen: Practical Differential Diagnosis in Surgical Neuro- E-cadherin and catenins in sporadic, 1216-1224 pathology, 240 deletions of chromosome 4 early in pathogenesis of, 169-177 Shi, Gu, & Taylor: Antigen Retrieval Techniques: Immunohistochemis- proliferative activity as predictor of metastasis in, 401-409 try and Molecular Morphology, 351 endometrial Weiss & Goldblum: Enzinger and Weiss’s Soft Tissue Tumors, 1414 molecular pathology of hyperplasia and, 569-577 Brain tumors transitional cell, with a benign ovarian Brenner tumor, 230-232 immunohistochemical study of benign, atypical, and anaplastic gallbladder meningiomas, 970-975 oa CIP1 in, 7 Breast hepatocellular female, lymph nodes in, 178-187 Fas and Fas-related molecule expression in, 250-256 Breast cancer genomic instability in, 698-703 cyclin E expression in ductal carcinoma, 89-94 p27! and p21““F!/ClP! in, 778-784 ductal carcinoma in situ (DCIS) CD34-positive sinusoidal endothelial cells as risk factor for, apocrine, histologic classification and markers, 487-493 1363-1370 perineural invasion by atypical ductal hyperplasia and, 785-790 keratin 1 expression in, 873-879 dystroglycan, reduced expression in, 791-795 lung estrogen receptor beta expression in invasive, 113-118 telomerase expression and activity in, 188-195 genomic alterations in tubular, 222-226 nasopharyngeal invasive micropapillary carcinoma, 583-589 multidrug resistance protein 1 and glutathione-S-transferase-7 lobular carcinoma in situ, loss of chromosome 16q, in, 292-296 in, 1240-1244 p53, c-erbB, and the cell cycle in node-negative, 311-319 CC chemokine expression in, 42-49 primary mammary small-cell carcinoma, molecular analysis of, neuroendocrine, of skin, morphologic diversity of, 680-689 753-757 odontogenic, pigmented intraosseous, of maxilla, 880-884 tyrosine kinase activation in, 1344-1350 pancreatic with aromatase in fine-needle aspirates, 348-351 intraductal papillary components of, 834-841 Brenner tumor prostate benign ovarian, with transitional cell carcinoma of endometrium, perineural invasion in, 828-833 230-232 Gleason score 7, genetic changes in, 1392-1397 Bronchioloalveolar carcinomas Gleason grading, interobserver reproducibility, 74-80, 81-88 absence of Jaagsiekte sheep retrovirus DNA and RNA in, 1039- loss of EGR1 corepressor NAB2 in, 935-939 1042 renal cell mucinous, mucin gene expression pattern in, 274-281 CD9/motility-related protein 1 in papillary and chromophobe, 1071-1077 cell proliferation, microvessel density, and CD44 in, 1209-1215 C-ERBB-2 genetic markers in (Editorial), 1027-1028 as marker for apocrine ductal carcinoma in situ of breast, 487- papillary, morphologic typing of, 590-595 493 pigmented clear cell, with melanocytic differentiation, 233-236 overexpression of p53 and, in node-negative breast cancer, 311- SPARC expression in, 1064-1070 319 subtypes of, Pax-2 expression in, 282-287 HUMAN PATHOLOGY Volume 32, No. 12 (December 2001) thyroid Central nervous system tumors papillary, Hashimoto’s-associated, 24-30 atypical teratoid/rhabdoid tumor, chromosome 22q dosage in, vulvar 156-162 squamous cell, pRB2/p130 and a in, 49 Pathology of Tumors of the Central Nervous System [book review], ‘arcinoma cells 663-664 hepatocyte growth factor expression by, in non-small cell lung Cervix, uterine cancer, 57-65 cervical-vaginal smears, telepathology system for, diagnosis of, ‘arcinoma ex pleomorphic adenoma 1218-1322 pathologic analysis of, 596-604 loss of heterozygosity at 11q23.3 in squamous cell carcinoma of, Jarcinoma in situ 475-478 flat urothelial, diagnostic aid for, 997-1002 lymphoepithelioma-like carcinoma of, human papillomavirus ‘ardiac amyloidosis and, 135-138 late-onset, with new transthyretin, 237-239 MUC4 expression in dysplastic disorders of, 1197-1202 ‘ardiomyocyte apoptotic bodies p53 homologue p63 expression in, for classification of, 479-486 thanatosomes and (Correspondence), 894-895 squamous intraepithelial lesions of, cytokeratin 1, 4 and, 1351- ‘ardiomyopathy 1355 arrhythmogenic right ventricular, pathologic findings, 1078-1086 superficial cervicovaginal myofibroblastoma, 715-725 ‘aspase 7 Chagas’ myocarditis downregulation of, as marker of colon carcinoma, 461-467 overexpression of neural cell adhesion molecule in, 149-155 vaspases Chemokines in biology of apoptosis, 1029-1038 CG, expression of in nasopharyngeal carcinoma, 42-49 ‘astieman’s disease, multicentric RANTES, in pulmonary Wegener’s granulomatosis, 320-326 viral interleukin-6 and latent nuclear antigen-1 in lymphoid cells Children, see Pediatric pathology in, 95-100 Cholangiocarcinoma Jatenin, a- intrahepatic, endogenous galectin-1 and galectin-3, 302-310 co-downregulation of, in prostatic adenocarcinoma, 849-855 Cholangiocytic apoptosis ‘atenin, B- in chronic ductopenic rejection, 823-827 co-downregulation of, in prostatic adenocarcinoma, 849-855 Cholecystitis mutations in, in endometrial hyperplasia and carcinoma, 574-575 leptospirosis mimicking, in athletes at a triathalon, 750-752 prognostic significance of in synovial sarcoma, 257-263 Chondrosarcoma Catenins extraskeletal myxoid, 1116-1124 in sporadic colorectal carcinoma, 1216-1224 Chromophobe renal cell carcinoma 1C chemokines CD9/motility-related protein 1 in, 1071-1077 expression of by macrophages in nasopharyngeal car, cinoma, Chromosomal aberrations 42-49 pulmonary inflammatory pseudotumors, 2p23 in, 428-433 ‘D9 Chromosome 2p13 in papillary and chromophobe renal cell carcinomas, 1071-1077 in metanephric adenoma, 101-104 ‘D10 Chromosome 4 in diffuse large B-cell lymphomas, 954-962 deletion of early in pathogenesis of colorectal carcinoma, 169- 1D15 177 as negative marker for pleural epithelial mesothelioma, 529-536 Chromosome 9 D2 in progression of bladder carcinoma, 468-474 in bone marrow mast cells in systemic mastocytosis, 545-552 Chromosome 11q 1D34 loss of heterozygosity on, in lung carcinoids, 333-33 in renal cell carcinoma, 1209-1215 Chromosome 16q in sinusoidal endothelial cells, as risk factor for hepatocellular loss of, in lobular carcinoma in situ, 292-296 carcinoma, 1363-1370 Chromosome 22q vs. tenascin, for differentiation dermatofibroma from dermatofi- dosage in atypical teratoid/rhabdoid tumors, 156-162 brosarcoma protuberans, 50-56 in composite extrarenal rhabdoid tumors, 1102-1108 ‘D44 Chronic B-cell leukemia cell adhesion proteins in prostatic adenocarcinoma, 849-855 CD5—/CD10-—, adhesion molecule expression in, 66-73 in leiomyosarcoma diagnosis, 1190-1196 Chronic lymphocytic leukemia in renal cell carcinoma, 1209-1215 adhesion molecule expression in, compared with CD5—/CD10- 1D44H chronic B-cell leukemia, 66-73 markers for pleural epithelial mesothelioma, 529-536 Cirrhosis D117 genomic instability in chronic viral hepatitis and hepatocellular in gastrointestinal stromal tumor, 578-582 carcinoma, 698-703 CD117 (Kit) vitronectin as marker of mature fibrosis in, 1356-1362 in bone marrow mast cells in systemic mastocytosis, 545-552 Classic cadherins type I tell adhesion molecules in urothelial neoplastic progression, 18-23 Nr-CAM in hyperplastic and neoplastic pancreatic tissue, 396-400 Clear cell carcinoma Cell cycle histologic diagnosis of Gleason grade 1 prostatic adenocarci- accelerated, and poor prognosis in node-negative breast cancer, noma, 441-446 311-319 Clinical pathology Cell cycle regulators curricular trends in, nationwide survey, 1149-1150 alterations of in nonfamilial retinoblastoma, 537-544 Clinicopathologic analysis and survivial in epithelial ovarian tumors, 808-813 adult-to-adult live donor liver transplantation, 814-822 cyclin-dependent kinase inhibitors (Editorial), 769-770 extraskeletal myxoid chondrosarcoma, 1116-1124 repp86, and progression in endometrioid adenocarcinoma, 605- nonlupus nephritides in systemic lupus erythematosus, 1125-1135 614 of superficial acral fibromyxoma, 704-714 Cell cycle-associated proteins Clonality cyclin E expression in breast ductal carcinoma, 89-94 of adrenal cortical proliferative lesions, 1232-1239 pRB2/p130 and p27sP in vulvar squamous cell carcinoma, 49 of Hodgkin’s lymphoma of T-cell type, 1269-12 1432

See more

The list of books you might like

Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.
DMCA & Copyright: Dear all, most of the website is community built, users are uploading hundred of books everyday, which makes really hard for us to identify copyrighted material, please contact us if you want any material removed.
Copyright @ PDFdrive.to, 2022 | We love our users